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1 Introduction 
1.1 Axonal outgrowth and regeneration in the Central Nervous 
 System (CNS) 
1.1.1 Axonal outgrowth in the developing CNS 
How neurons extend their axons and, in particular, how this process is regulated is a 
fascinating problem as the correct growth of axons to their targets underlies the 
establishment of precise functional connections in the developing brain and is the basis for 
successful axonal regeneration and functional recovery after nerve injury. While the 
lengthening of a neurite occurs by extension of axially oriented bundles of microtubules in 
the axon, the direction and pattern of growth are directed by a highly specialized structure 
at the tip of each growing neurite, the growth cone. Both movements are coupled and 
thereby lead to a directional elongation of the axon. Growth cones resemble finger like 
structures that constitute the locomotory organelles of neurons and are extremely motile 
through a network of actin filaments at their leading edge. Time-lapse videomicroscopy 
elucidated growth cone dynamics and demonstrated that the growth cone advance is 
saltatory, with frequent advances and pauses, and that growth cones remain motile during 
pauses and make minute advances and retractions, accompanied by extensive cytoskeletal 
remodelling of the growing tip (reviewed by Mason and Erskine, 2000). Rapid extension 
was shown to occur along other fascicles of neurites when growth cones could follow the 
axons of pioneer neurons, pausing was predominant at choice points such as the CNS 
midline (reviewed by Mason and Erskine, 2000). In the course of axon extension, 
processes can fasciculate to form bundles with other axons or defasciculate to choose a 
separate pathway and they can branch.  
For most CNS neurons of higher vertebrates, the elongation of a principal axon is confined 
to a few days or weeks during development (Chen et al., 1997; Dusart et al., 1997; 
reviewed by Ferretti et al., 2003; Li et al., 1995; Prang et al., 2001; Woodhams et al., 
1993). The molecular processes required for axon growth might be inactivated after this 
period in order to stabilize existing connections (reviewed by Fawcett, 1992; Skene, 1989). 
The growth-associated protein GAP-43, for example, which is important for axonal 
outgrowth during development and regeneration, is highly expressed in growth cones of 
axon-extending neurons and is strongly downregulated in many brain regions after 
neuronal maturation. Recently, it was suggested that a target-derived retrogradely 
transported repressive factor might account for this decline in GAP-43 expression (Karimi-
Abdolrezaee and Schreyer, 2002; Woolf et al., 1990). As a consequence, such a 
developmental inactivation or retention of growth-promoting factors might lead to a strong 
decline of axon growth and regeneration in mature neurons. Previous transplantation and 
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co-culture experiments, which revealed a strong intrinsic growth state of embryonic 
neurons in a mature environment, support this hypothesis (reviewed by Caroni, 1997; Chen 
et al., 1997; Dusart et al., 1997; Li et al., 1995; Prang et al., 2001; Woodhams et al., 1993). 
A few proteins associated with axon growth during both, development and regeneration, 
have been identified in recent years, which belong to different classes of molecules with 
diverse functions, ranging from signal transduction components and transcription 
regulators to cell surface molecules and growth-related proteins (reviewed by Caroni, 
1997; Skene, 1989). Examples are GAP-43, CAP-23 and cell adhesion molecules (CAMs) 
(reviewed by Skene, 1989; Caroni, 1997. See also section 1.1.4). As these neuronal 
proteins are strongly expressed in axon-extending neurons during development and are re-
induced after nerve lesion, they might be part of an intrinsic molecular elongation program 
of a neuron. Extracellular matrix molecules are also able to promote or restrict axon 
growth and to modify the behaviour of growth cones in response to environmental cues. 
Laminin, for example, is growth promoting, whereas versican and certain tenascins impede 
axonal growth (Asher et al., 2002; Hopker et al., 1999; Schmalfeldt et al., 2000). 
Furthermore, cell-adhesion molecules of the Ig-superfamily are known to subserve several 
functions during developmental axon growth, for instance fasciculation, interaction with 
cell surface molecules and pathway selection (Dodd et al., 1988; reviewed by Rutishauser 
and Jessell, 1988) and they support regeneration of retinal ganglion cells (RGCs) in fish 
(Stuermer et al., 1992). Neurotrophic factors are another class of molecules that are 
required not only for neuronal survival but also for neuronal differentiation (reviewed by 
Bibel and Barde, 2000; Davies, 2000; Huang and Reichardt, 2001; McAllister, 2001). 
Distinct neurotrophins are secreted by target cells from which they are retrogradely 
transported to the outgrowing neurons in vivo (Ginty and Segal, 2002) and some 
neurotrophins are sufficient to induce neurite processes in PC12 cells in vitro (reviewed by 
Vaudry et al., 2002).  
Axon pathfinding and guidance is one aspect of the differentiation program that occurs in 
postmitotic neurons and polarizes the cells. As an axon grows away from the neuronal cell 
body, it must choose among various substrates and recognize environmental cues in order 
to reach its specific target. It then must recognize and enter the target area, where extensive 
terminal arborisation occurs, and synapse with the appropriate cells. These processes 
depend on the interpretation of combinations of incoming signals by particular growth 
cones. Molecules outside of growth cones which influence the direction of axon outgrowth 
– the environmental cues – are relevant as well as molecules that are expressed in and on 
growing axons, which include receptors for guidance cues and elements of signal 
transduction pathways that mediate changes in growth cone behaviour (reviewed by 
Daston and Koester, 1996; Keynes and Cook, 1995; Schwab, 1996). Among the 
environmental cues that attract or repel axons are the netrins, which have been shown to 
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function as midline chemoattractants (Kennedy et al., 1994; Serafini et al., 1994), members 
of the semaphorin or collapsin family that are important for the patterning of CNS 
projections by growth-repulsion and -attraction (Fan and Raper, 1995; Messersmith et al., 
1995; Puschel et al., 1995), the ephrin-Eph receptor system, which is known to play a role 
in contact repulsion and retinotectal map formation, and the Robo-Slit/Comm system 
involved in midline guidance (reviewed by Cook et al., 1998; Holland et al., 1998; Valtorta 
and Leoni, 1999; Wilkinson, 2001; Yamamoto et al., 2002). Different mechanisms for 
growth cone guidance have been described: contact attraction and contact repulsion, 
mediated by short-range cues such as cell surface- and matrix-associated components, as 
well as chemoattraction and chemorepulsion, mediated by diffusible long-range cues 
(reviewed by Tessier-Lavigne and Goodman, 1996). Yet, some guidance molecules are not 
exclusively attractive or repulsive, but rather bifunctional, depending on multiple features, 
for instance the type of neuron, developmental age, presence of other guidance molecules 
acting on the same growth cone and modulations of signal transduction pathways used by 
guidance molecules (reviewed by Mueller, 1999; Shewan et al., 2002). Moreover, a single 
growth cone can respond to the same guidance cue in opposing ways depending on the 
level of intracellular signalling molecules such as calcium or cyclic nucleotides (reviewed 
by Mason and Erskine, 2000; Song et al., 1997). It is able to integrate the information of 
multiple guidance cues in a highly coordinated, hierarchical manner and to translate them 
into proper behavioural changes. Signalling mechanisms responsible for triggering axon 
extension have been identified in recent years and provided a link between guidance cues 
and the cytoskeletal organization of a growth cone. For instance, Rho-like GTPases, a 
family of small GTP-binding proteins including Cdc42, Rac and Rho are activated by axon 
guidance receptors and are highly expressed in certain brain regions during periods of 
neurite outgrowth. They function in the formation of growth cone filopodia and 
lamellipodia as well as in growth cone collapse by indirectly targeting the actomyosin 
system at the leading edge (reviewed by Mueller, 1999; Patel and Van Vactor, 2002; Yuan 
et al., 2003). The importance of so-called lipid rafts in growth cone signalling and 
migration has recently become evident. It was shown that two CAMs, L1 and N-cadherin, 
but not ß1-integrin, are regionally concentrated in specialized microdomains of the growth 
cone cell membrane and that disruption of these lipid rafts prevented migration of growth 
cones on L1 or N-cadherin substrates, yet growth cone motility was unaffected on a 
laminin substrate, to which ß1-integrin binds (Nakai and Kamiguchi, 2002). Moreover, it 
was demonstrated that the localization of distinct proteins to lipid rafts of the growth cone 
membrane is regionally regulated in a neuron and becomes altered during development, 
thereby regulating signal transduction through these cell surface molecules in a precise 
way (Nakai and Kamiguchi, 2002). In addition, calcium transients were shown to occur in 
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growth cones in vitro and in vivo that determine the rate of growth cone advancement 
(Gomez and Spitzer, 1999; Gomez and Spitzer, 2000). 
To conclude, molecules that were found to be associated with various aspects of axon 
growth such as axon extension, adhesion, attraction, repulsion, fasciculation and branching 
encompass neuronal proteins as well as extracellular molecules, associated with glial cells 
or the extracellular matrix, and diffusible factors. Thus, it seems that axon growth is not 
determined by a single molecule but rather is an interplay between multiple factors, which 
renders the control of a neuron’s growth state very complex. Neuron-intrinsic molecules 
appear to likewise play a role in this process, as do environmental cues. 
1.1.2 Axonal regeneration in the CNS 
The response to injury and the potential for axonal regeneration in the CNS are highly 
variable and depend largely on the neuronal cell type affected, the developmental age, type 
of injury and length of the remaining myelinated axon segment. Moreover, regeneration of 
CNS neurons differs largely in different organisms. Whereas a good axonal regeneration 
with functional recovery is observed in the CNS of fish and amphibians (Stuermer et al., 
1992) and in the PNS of higher vertebrates, the regenerative response in the CNS of birds 
and mammals is very poor (Kapfhammer, 1998). Mature CNS neurons of higher 
vertebrates are unable to regenerate their axons over long distances and to reconnect to 
their target cells. However, central neurons show some degree of plasticity called axonal 
sprouting, which occurs at cut axon stumps close to the lesion site but is different from 
long distance growth (Caroni, 1997). For instance, adult DRG neurons, which are bipolar 
neurons possessing a peripheral and a central axon branch, show extension of long axons 
in culture after peripheral axotomy but display a distinct growth mode characterized by 
less elongation and higher branching after central transection. The transition between 
distinct modes of axon growth depends on different patterns of gene expression that are 
partly triggered by the lesion-induced interruption of axonal transport (Smith and Skene, 
1997). Despite the failure of lesioned CNS neurons to regenerate, a process called 
collateral sprouting occurs in uninjured neurons, which are located close to the denervated 
target cell and can form axon collaterals and sprout into the denervated region, thereby 
functionally compensating to some part for the nerve fibers lost by the lesion (reviewed by 
Kapfhammer, 1997). Yet, collateral sprouting and axonal regeneration are highly age-
dependent processes which decrease considerably with developmental maturation of the 
CNS in vitro as well as in vivo (Chen et al., 2000; Dusart et al., 1997; reviewed by 
Kapfhammer, 1997; Li et al., 1995; Prang et al., 2001; Woodhams et al., 1993).  
Another aspect of CNS regeneration is the induction of an extensive gliosis by reactive 
astrocytes and microglial cells at the lesion site, which can proliferate, migrate into the 
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lesion site, phagocytose axonal debris, remove synapses and produce pro-inflammatory 
cytokines (reviewed by Turner et al., 1998). Glial activation results in the formation of a 
glial scar containing inhibitory extracellular matrix molecules such as chondroitin sulphate 
proteoglycans (CSPGs). Thus, the glial scar represents a physical and inhibitory barrier to 
axonal regrowth, which might contribute to the failure of regeneration (reviewed by Stichel 
and Muller, 1998). Yet, in microlesions that leave intact the glial environment, CNS axons 
still do not regenerate (Davies et al., 1996), indicating that multiple restricting mechanisms 
must exist. Although activated glial cells might be detrimental to the injured neuronal 
network by expression and secretion of pro-inflammatory and growth-impeding molecules, 
they also might be beneficial by expression and secretion of cell adhesion molecules, e.g. 
PSA-NCAM and N-cadherin, growth factors such as nerve growth factor (NGF), ciliary 
neurotrophic factor (CNTF) or fibroblast growth factor (FGF), and by influencing the 
composition of the extracellular matrix (Aubert et al., 1995; Rudge and Silver, 1990; 
reviewed by Turner et al., 1998). Furthermore, growth factors are secreted by many target 
cells and are retrogradely transported to the appropriate axon-extending neurons. 
Interruption of the axonal transport, e.g. by nerve transection, thus might contribute to the 
poor regenerative capability of many CNS neurons due to the lack of growth-promoting 
factors (DiStefano et al., 1992).  
The success of axon regeneration in the adult mammalian brain depends on the presence of 
growth-permissive environmental conditions as well as specific properties of the affected 
neurons. Additional factors restricting the regenerative response of CNS neurons are, for 
example, the CNS environment, which displays unfavourable growth conditions. It has 
been shown that components of CNS myelin, such as the NI-35/250 antigens, later 
identified as the Nogo proteins (Chen et al., 2000; GrandPre et al., 2000; Prinjha et al., 
2000), and the myelin-associated glycoprotein MAG (McKerracher et al., 1994), induce 
growth cone collapse and, by inhibiting neurite-growth, crucially account for the failure of 
axon regrowth and restriction of collateral sprouting after CNS lesions (Caroni and 
Schwab, 1988b; reviewed by Kapfhammer, 1997; Li et al., 1996; Schwab et al., 1993). 
Consistent with this is the situation in fish, where oligodendrocytes lack growth-impeding 
molecules and, instead, support axonal elongation of fish as well as rat retinal axons 
(Stuermer et al., 1992). Conversely, sprouting of lesioned axons in mammals is 
considerably enhanced after unilateral pyramidotomy and lesion of the dorsal root, 
respectively, in the absence of myelin (Schwegler et al., 1995; Vanek et al., 1998). 
Moreover, two chondroitin sulfate proteoglycans, brevican and versican, that are expressed 
on differentiated oligodendrocytes are additional components of CNS myelin that 
contribute to its nonpermissive substrate properties for axonal growth (Asher et al., 2002; 
Niederost et al., 1999; Schmalfeldt et al., 2000). The presence of several myelin-associated 
growth inhibitors that act independently might explain why in MAG-deficient mice axonal 
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regeneration is not improved (reviewed by Bartsch, 1996; Bartsch et al., 1995). The 
capacity of CNS neurons for regeneration declines sharply with the appearance of mature 
oligodendrocytes and myelin. Accordingly, the growth potential is not impeded in young 
CNS tissue with immature oligodendrocytes that do not induce growth cone collapse 
(Schwab and Caroni, 1988). Thus, the regenerative potential of CNS neurons correlates 
inversely with the maturation of oligodendrocytes expressing myelin-associated growth 
inhibitors. Yet, the ability of retinal ganglion cells to extend neurites on optic nerves is lost 
before the optic nerve becomes myelinated (Ferretti et al., 2003; Shewan et al., 1993) and 
regeneration remains limited in regions where myelin is not a major component of the scar 
such as in CNS grey matter or in non-myelinated retina (Rudge and Silver, 1990), 
suggesting that lack of myelin proteins is not sufficient for the occurrence of regeneration. 
This points to the existence of further growth-determinants. Embryonic neurons are 
capable of extending fibers in the inhibitory environment of adult CNS tissue and even 
can, for some neuron types, grow longer axons than in the absence of myelin-associated 
molecules, indicating that a developmental change in the responsiveness of CNS neurons 
to myelin-associated growth inhibitors occurs (Bandtlow and Loschinger, 1997; Davies et 
al., 1993; Li and Raisman, 1993; Shen et al., 1998). Accordingly, after implantation into a 
CNS lesion site of an adult animal, embryonic striatal neuroblasts exhibit long fiber growth 
on non-permissive CNS tissue to reach their appropriate targets (Wictorin et al., 1990). 
These results demonstrated that the growth-inhibition by a non-permissive environment 
can be overcome by neurons which exhibit a strong intrinsic growth potential and might 
lack receptors for the inhibitory myelin-associated molecules and that a loss of intrinsic 
growth capacity occurs during development. Such an intrinsic axon elongation program 
might differ from a terminal sprouting and branching program which implies that a switch 
in gene expression might direct a distinct type of growth mode (Caroni, 1997). Recently, 
Goldberg et al. demonstrated that for retinal ganglion cells this switch could be induced by 
contact to amacrine cells, i.e. by a contact mediated signaling event at the dendrite of the 
neurons (Goldberg et al., 2002b). This result is consistent with the finding by Dusart et al., 
who described that the decrease in regenerative potential of Purkinje neurons correlates 
with the onset of synaptogenesis and dendritic remodelling of these cells (Dusart et al., 
1997).  
Intrinsic determinants that might influence the axon growth capability are, for example, the 
growth-associated proteins GAP-43 and CAP-23 (Laux et al., 2000; Skene and Willard, 
1981a; Skene and Willard, 1981b), which are expressed abundantly at the growth cone 
surface during fiber outgrowth and synapse formation and which are downregulated in 
many brain regions during development when the growth capacity of CNS neurons 
strongly declines (Benowitz and Routtenberg, 1997; Caroni, 1997). Myelination of CNS 
axons and expression of the growth-associated protein GAP-43 in CNS neurons are 
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complementary and are inversely correlated regarding the growth potential of these 
neurons: high levels of GAP-43 expression combined with light myelination promote 
neuronal plasticity, whereas weak expression of GAP-43 but dense myelination restrict 
plasticity (Kapfhammer and Schwab, 1994a; Kapfhammer and Schwab, 1994b). A further 
candidate molecule that determines the growth potential of CNS neurons is the anti-
apoptotic protein bcl-2, which, independently of its function to promote cell survival, 
stimulated regeneration of severed retinal ganglion cell axons in culture and in vivo (Chen 
et al., 1997). Yet, this effect could not be reproduced in the same type of neurons and more 
recent studies pointed to a sole role of bcl-2 in promoting survival of injured RGCs 
(Chierzi et al., 1999; Goldberg et al., 2002a; Lodovichi et al., 2001). Another determinant, 
cAMP, was revealed by various groups to be implicated in signalling a neurons growth 
response. For instance, when supplied simultaneously with neurotrophic factors, 
physiological levels of electrical activity or cAMP promote neurotrophin responsiveness 
and dramatically potentiate axon outgrowth of RGCs (Goldberg et al., 2002a). Moreover, 
high levels of cAMP can overcome the inhibition of axonal growth by myelin components 
(Cai et al., 1999) and protein kinase A (PKA) and polyamines were shown to be 
downstream targets of this signalling pathway in DRG neurons (Cai et al., 2002).  
Improvements of axonal regeneration: 
Several approaches to encourage regeneration have focused on addressing individually the 
varying impediments to growth. As axonal growth is dually regulated by extrinsic and 
intrinsic determinants, experimental approaches that aimed at the improvement of CNS 
regeneration intended to both, rendering the inhibitory CNS environment growth-
permissive for regenerating axons and stimulating the intrinsic growth properties of 
lesioned CNS neurons. As a result, regeneration of CNS axons was found to be improved 
under certain experimental conditions with limited functional recovery in some cases, but a 
regrowth of most fiber bundles with a complete re-innervation of the appropriate target 
was never achieved. Some approaches are outlined below:  
Reduction of reactive gliosis or eliminating the glial scar and its inhibitory components, 
either by gliotoxic drugs or by collagenase digestion, results in improved regeneration of 
CNS nerve fibers (Gimenez y Ribotta et al., 1995; Hermanns et al., 2001; Stichel et al., 
1999; reviewed by Stichel and Muller, 1998). Removal of glycosaminoglycan chains from 
chondroitin sulphate proteoglycans (CSPGs) attenuates CSPG inhibitory activity, thereby 
promoting regeneration of severed axons and leading to functional improvements in the 
CNS in vitro and in vivo (Bradbury et al., 2002; Moon et al., 2001; Zuo et al., 1998). A 
conditioning lesion (a prior injury of the peripheral branch of DRG neurons followed by a 
second axotomy of the central branch) stimulates the axonal growth program of DRG 
neurons as shown, for example by upregulation of GAP-43, and increases the sprouting 
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response of their central branches into the denervated target area in the spinal cord 
(reviewed by Kapfhammer, 1997).  
Neutralization or inhibition of myelin components with the monoclonal antibody IN-1 or 
antibodies specific to Nogo leads to a pronounced regeneration of lesioned spinal cord 
axons in the adult rat, which is accompanied by functional improvements such as 
locomotor recovery (Bregman et al., 1995; Caroni and Schwab, 1988a; Merkler et al., 
2001; Schnell and Schwab, 1990; Tatagiba et al., 1997; Thallmair et al., 1998; Z'Graggen 
et al., 1998). This is consistent with a significantly enhanced axonal sprouting response 
after lesion of the corticospinal tract in a mature rat in which myelination was inhibited by 
neonatal X-irradiation (Vanek et al., 1998). Moreover, blocking of the Nogo-66 receptor, 
which is involved in Nogo-mediated growth inhibition, by application of a competitive 
receptor antagonist elicited a clear axon sprouting response of the lesioned corticospinal 
tract in the rat and improved functional recovery (GrandPre et al., 2002). In addition, 
pharmacological inactivation of the rho-GTPase allowed retinal neurons to extend axons 
on a myelin substrate, which under normal conditions is inhibitory, and promoted CNS 
regeneration of retinal neurons after optic nerve crush in vivo (Lehmann et al., 1999). 
Transgenic overexpression of growth-associated molecules like GAP-43 and CAP-23 in 
CNS neurons enhances axonal sprouting and plastic changes at axon terminals and 
synapses and stimulates neurite outgrowth in culture (Aigner et al., 1995; reviewed by 
Benowitz and Routtenberg, 1997; Holtmaat et al., 1997). Upon co-expression of CAP-23 
and GAP-43 axon regeneration of DRG neurons was further potentiated in vitro and in vivo 
(Bomze et al., 2001). Transgenic overexpression of the anti-apoptotic protein bcl-2 
enhanced survival and improved regeneration of retinal ganglion cells (Chen et al., 1997). 
Application of neurotrophins, e.g. by implanting cells genetically engineered to produce 
and secrete various trophic molecules, enhances local axonal sprouting and, to some 
degree, axonal regrowth of adult lesioned CNS neurons (reviewed by Bregman et al., 2002; 
Broude et al., 1999; Eagle et al., 1995; Gage et al., 1990; Grill et al., 1997; Liu et al., 1999; 
Schnell et al., 1994; Woodhams and Atkinson, 1996). Transplantation of embryonic 
nervous tissue, dissociated Schwann cells, peripheral nervous tissue or olfactory ensheating 
cells, all of which are permissive for axonal growth, favours regeneration of some axonal 
types but is not sufficient to promote regenerative axonal outgrowth in every neuronal cell 
type. Enhancement of CNS axon regeneration was first shown by grafting peripheral 
nervous system tissue into the lesion site (David and Aguayo, 1981; Richardson et al., 
1980). Some of the regenerating fibers were shown to form functional connections in their 
target regions (Cheng et al., 1996; Keirstead et al., 1989; Sauve et al., 1995; Thanos, 
1992). Later, either suspensions of dissociated Schwann cells that were injected into the 
lesion site or transplantation of Schwann cell seeded guidance channels or application of a 
Introduction 
 
9
Schwann cell conditioned medium have also been shown to promote axon growth of CNS 
neurons (Li and Raisman, 1994; Stichel et al., 1996; Xu et al., 1995). Injections of 
suspensions of olfactory ensheating cells (OECs) into a corticospinal tract lesion induced 
axon elongation of the cut axons over the lesion site into the host tissue and resulted in 
successful functional improvements (Keyvan-Fouladi et al., 2002; Li et al., 1997; reviewed 
by Raisman, 2001). Although the majority of such experiments was done in spinal cord, 
successful regeneration could also be demonstrated in other CNS systems. Olivocerebellar 
fibers, for example, regenerate well and enter their target region under such permissive 
conditions (reviewed by Rossi et al., 1995) and neurons of the thalamic reticular nucleus 
exhibit an established propensity to regenerate their axons along the graft which is 
accompanied by upregulation of c-Jun and GAP-43 (Vaudano et al., 1998). Moreover, 
Schwann cell grafts promoted the regeneration of hippocampal fibers to the mamillary 
body after transection of the postcommissural fornix in adult rats (Stichel et al., 1996). 
Axonal regeneration and functional recovery of adult lesioned CNS neurons was similarly 
enhanced by grafting embryonic CNS tissue into the lesion site in combination with supply 
of neurotrophins (Coumans et al., 2001; Tuszynski and Gage, 1995). 
In summary, these experiments elucidate that axonal re-growth in the CNS is possible 
under certain conditions but they also clearly show that, despite the remarkable 
achievements in promoting regeneration in the mammalian CNS, the success is still 
incomplete. Furthermore, it becomes clear that regeneration depends on the interplay 
between environmental cues and intrinsic properties of axotomized neurons. 
1.1.3 Axonal outgrowth and regeneration in the rat cerebellum and 
 entorhinal cortex during neuronal development 
Cerebellum:  
The time course of neurogenesis and axon outgrowth is well described in developing rat 
cerebellum. Purkinje neurons are born between E14 and E15 in the ventricular 
neuroepithelium, migrate superficially from E17 to settle beneath the external granular 
layer (EGL) and form a distinct Purkinje cell layer (Altman and Bayer, 1985). From E18 
on, Purkinje cells project to their targets, the deep cerebellar nuclei and vestibular nuclei, 
with which they form inhibitory GABAergic synapses (Eisenman et al., 1991). Birth and 
axon growth of other cerebellar neurons occurs later in development and neurogenesis of 
granule cells even extends to P21 (Altman and Bayer, 1978). Purkinje cells are among the 
most resistant neurons to axotomy and the most refractory to axonal regeneration (Dusart 
et al., 1997). Lesioned Purkinje cells of the adult rat or mouse survive axotomy but do not 
regenerate their axons, which appear as thickened processes with large terminal clubs at 
their ends (Dusart and Sotelo, 1994; Rossi et al., 1995). Following transection of rat 
Purkinje cell axons in organotypic slice cultures, Purkinje neurons survive before or after a 
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critical period during the first postnatal week, the time of extensive synaptogenesis, but 
they only regenerate their axons if taken from fetal animals. When axotomized at P7 or 
later, rat Purkinje neurons fail to re-grow their axons (Dusart et al., 1997). Thus, Purkinje 
cell survival and regeneration are obviously age-dependent (Gianola and Rossi, 2001). 
Rescue of Purkinje neurons by inhibiting protein kinase C (PKC) does not enhance their 
regenerative capability (Ghoumari et al., 2002). Even after rendering the CNS environment 
permissive by transplanting peripheral nerve or fetal CNS tissue into the lesion site, 
Purkinje neurons from older developmental stages (e.g. P10) still did not regenerate 
(Dusart et al., 1997). When olivocerebellar and Purkinje cell axons from adult rodents are 
severed in the cerebellar white matter and become confronted with target-specific 
embryonic tissue or dissociated Schwann cell grafts, the former regenerate vigorously into 
the transplant, whereas the latter invariably fail to do so (reviewed by Rossi et al., 1997; 
Rossi et al., 1995). Similarly, in contrast to neurons of the thalamic reticular nucleus, deep 
cerebellar nuclei and inferior olive, the cell body reaction in response to axotomy with 
subsequent grafting of growth-permissive tissue is only weak in Purkinje neurons, which 
do not upregulate c-Jun or GAP-43, correlating with very poor regenerative capabilities 
(Vaudano et al., 1998; Zagrebelsky et al., 1998). After neutralization of myelin-associated 
growth inhibitors by IN-1 antibody application, Purkinje neurons exhibited an enhanced 
cell body response with upregulation of Jun-proteins, indicating that inhibitory myelin 
components are involved in the retrograde regulation of injury-associated gene expression 
(Zagrebelsky et al., 1998). Targeted overexpression of GAP-43 in cerebellar Purkinje cells 
induced axonal sprouting after axotomy but not long distance regeneration of the lesioned 
axons (Buffo et al., 1997). After lesion of the adult cerebellar cortex, subsets of Purkinje 
neurons strongly upregulated low-affinity nerve growth factor receptor p75 and showed a 
beaded varicose morphology with the appearance of recurrent axonal collaterals (Martinez-
Murillo et al., 1993). These examples demonstrate that the extent of cell body response is 
correlated to the regenerative potential and emphasize that a permissive local environment 
is not sufficient for successful regeneration of Purkinje cell axons but that intrinsic 
properties of axotomized neurons are important determinants for axonal regrowth as well 
(reviewed by Rossi et al., 1997; Zagrebelsky et al., 1998).  
Entorhinal cortex: 
Pyramidal cells of layers II and III of the entorhinal cortex project their axons to the ipsi-
and contralateral hippocampal formation to innervate the granule cells of the dentate gyrus 
and the pyramidal cells of the hippocampal CA-region. The perforant pathway terminates 
laminar-specific in the outer molecular layer of the fascia dentata and in the stratum 
lacunosum moleculare of the hippocampus proper where it forms excitatory glutamatergic 
synapses with the pyramidal neurons of the cornu ammonis regions CA1 to CA3 
(Frotscher, 1991). During development, axons of the entorhinal-hippocampal projection 
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are fist observed at E17 in the rat, yet the majority of fibers develop around birth and begin 
to form synapses from days 3-5 postnatally (Ceranik et al., 2000; reviewed by Turner et al., 
1998). It was shown that Cajal-Retzius cells, which seem to be required for layer-specific 
termination of entorhinal afferents (Super et al., 1998), form a pioneer projection from the 
hippocampus to the entorhinal cortex to provide a template for entorhinal axons that later 
grow out in the opposite direction (Ceranik et al., 2000). In addition, hitherto unidentified 
attractive, membrane-associated molecules, restricted to the proper target region of 
entorhinal fibers at a distinct developmental stage, seem to influence the ingrowth of these 
hippocampal afferents (Skutella et al., 1999). Several molecules known to function in axon 
guidance, for example semaphorins and ephrins were shown to be involved in establishing 
the entorhinal-hippocampal connection (reviewed by Skutella and Nitsch, 2001; Stein et 
al., 1999; Steup et al., 1999).  
After lesion of the perforant path in an organotypic slice culture model, young entorhinal 
fibers were shown to re-grow their axons and to terminate in a layer-specific way, just as in 
vivo (Frotscher et al., 1997). Furthermore, commissural fibers from the contralateral 
hippocampus exhibit a reactive sprouting response after lesion, which is also layer-specific 
and leads to new synapses on the denervated dendrites (reviewed by Bechmann and Nitsch, 
2000; Savaskan and Nitsch, 2001). The culture model, in which entorhinal cortex slices are 
co-cultured with hippocampal slices, revealed that entorhinal fibers re-innervate the 
hippocampus only if perforant path lesions are made before 2-3 weeks in culture, 
equivalent to a postnatal age of 11-18 days, and that this developmental decline in 
regenerative capability is due to maturation of the entorhinal neurons and not that of the 
hippocampal target (Li et al., 1995; Prang et al., 2001; Woodhams et al., 1993). Treatment 
with trophic factors after perforant path lesion, e.g. by addition of a Schwann cell 
conditioned medium or fibroblast growth factor, can ameliorate the decline in regenerative 
ability of entorhinal pyramidal neurons with increasing developmental age (Woodhams 
and Atkinson, 1996). Moreover, Prang et al. showed an improvement of regeneration after 
application of the neurotrophins GDNF and NT-4 or by inhibiting intracellular signalling 
molecules such as G-proteins or protein kinase C (Prang et al., 2001). 
1.1.4 Axon growth-associated molecules 
As axon elongation is confined to a few days or weeks during development and some 
growth-associated genes are downregulated in neurons after this period, it was suggested 
that maturation of a neuron is tightly linked to a repression of growth-related properties 
after completion of neuronal differentiation. Accordingly, the expression of some of the 
genes involved in axon growth might be transient during development and might be re-
induced during successful axon regeneration (reviewed by Skene, 1989). Consequently, it 
was searched for genes whose expression is correlated consistently with periods of axon 
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growth during both development and regeneration and whose expression is repressed as 
neurons mature (reviewed by Skene, 1989). In the past, a few proteins were identified that 
are very rich in axons or growth cones during fiber elongation and are tightly correlated 
with a neuronal “growth state”. These include the growth-associated proteins GAP-43 and 
CAP-23, actin and tubulin isoforms, the c-src tyrosine kinase and rho-GTPases, the neural 
cell adhesion molecule NCAM and its poly-sialylated form PSA-NCAM and the 
microtubule-associated proteins tau and MAP5 (Caroni, 1997; reviewed by Ferretti et al., 
2003; Patel and Van Vactor, 2002; Skene, 1989; Tucker et al., 1989). The number of gene 
families and molecules identified increases continuously and further proteins had been 
shown to be involved in different aspects of neurite outgrowth and regeneration, e.g. 
neurotrophic factors, integrins, extracellular laminins, transcription factors of the 
immediate early gene (IEG) family and chemorepulsive proteins (Caroni, 1997; Goldberg 
et al., 2002a; Holtmaat et al., 1998). 
Various groups identified differentially expressed genes by comparing the expression 
patterns of regenerating with non-regenerating systems on the one hand and gene 
expression in neurons before and after injury on the other hand. Altered expression was 
examined, for example, in neurons of dorsal root ganglia after sciatic nerve lesion 
(Mladinic and Wintzer, 2002; Newton et al., 2000; Xiao et al., 2002). Nevertheless, these 
approaches are problematic, because they also target genes that are not involved in long 
distance axon growth but rather are associated with general inflammatory reactions of the 
lesioned neurons. A few proteins were identified that are linked to different aspects of axon 
growth. Yet, no major regulators have been described so far that could mediate an intrinsic 
switch from a neuronal growth state to a “non-growth” state which allows stabilization of 
present axonal connections but restricts further axon growth. An important step towards 
understanding the molecular mechanisms underlying axon growth therefore will be to 
identify regulatory signals that, by controlling the expression of growth-associated genes, 
might determine a neuron’s propensity for axon growth. Possible regulatory signals are, for 
example, transcription factors. Hence, this protein class is outlined in the next chapter, as 
transcription factors were the main focus of the first approach of the present studies. 
1.2 Transcription factors 
Transcription factors are sequence-specific DNA binding proteins, which mediate changes 
in gene expression patterns in a cell in response to a specific challenge. They can act both 
as activators or repressors of gene transcription and exert this function by binding to 
discrete DNA motifs within and flanking a gene in a region of active chromatin, thereby 
determining the activity of the gene’s promotor. Some of the DNA motifs are conserved 
and share common consensus DNA sequences which are recognized by transcription factor 
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families, which themselves are often expressed in a tissue-specific, developmental or 
stimulus-specific manner. Members of one protein family share a conserved DNA-binding 
region, which allows binding to a specific consensus DNA motif. Transcription factors can 
enhance their transactivation potency by operating in a combinatorial fashion, forming 
hetero- or homodimers or interacting with other (multimeric) transcription factor 
complexes, which are bound to DNA nearby. Thus, various affinities for specific 
consensus sequences are obtained and a large diversity in the regulation of gene expression 
is guaranteed (Sockanathan, 2003; Struhl, 1991). Transcription factors are composed of 
different domains that serve distinct functions. In general, they possess a DNA-binding 
domain for binding to specific promotor or enhancer DNA regions of a target gene, a 
transactivation domain for interaction with the basal transactivation complex and 
sometimes an additional dimerization domain in order to form homo-or heterodimers with 
other transcription factors. Transcription factors often act sequentially in that they regulate 
the expression of other transcription factors, which in turn regulate the expression of 
downstream effector genes. 
1.2.1 Transcription factor classes 
Depending on whether transcription factors are induced by cellular stimulation or are 
present in quiescent cells in the absence of any external stimulus, one can discriminate 
between inducible transcription factors, for instance the Jun, Fos and Krox proteins which 
are encoded by immediate-early genes, and constitutive transcription factors, e.g. the basic 
leucine zipper proteins CREB or ATF-1, which are already bound to DNA and are 
activated by phosphorylation (reviewed in Herdegen and Leah, 1998). Another 
classification groups transcription factors into families of related proteins which share 
peptide domains involved in either specific DNA sequence recognition or dimerization 
with related proteins (He and Rosenfeld, 1991; Latchman, 1993; Struhl, 1991). Being 
characterized by a common DNA binding domain, members of a specific family of 
transcription factors hence recognize similar DNA motifs in promotor and enhancer 
regions of downstream target genes. In the following section, six examples for such 
transcription factor families are described in more detail as they were of interest for the 
studies reported in the first results section of this thesis. 
POU-domain proteins: The name POU was derived from four transcription factors which 
were first recognized to make up this protein family. These are the mammalian factors Pit1 
and the octamer binding proteins Oct1 and Oct2, furthermore the protein Unc86 from 
C.elegans (Herr et al., 1988). Within the POU family, transcription factors are further 
classified in class I to class V proteins according to the similarity of their common POU 
domain, which constitutes the bipartite DNA binding domain of these proteins (He et al., 
1989; Rosenfeld, 1991). The POU domain consists of a 70-80-amino acid POU specific 
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domain and a 60-amino acid POU homeodomain related to that found in homeobox (HOX) 
proteins, which are depicted below. Both domains are linked by a variable and poorly 
conserved spacer region (see also fig.3-2 in chapter 3). POU family members recognize a 
defined DNA sequence motif, known as the octamer element (He et al., 1989; Herr et al., 
1988; Rosenfeld, 1991; Verrijzer and Van der Vliet, 1993; Wegner et al., 1993). 
Basic helix-loop-helix (bHLH) proteins share a common structural motif of about 60 
amino acids, which is characterized by two α-helices, separated by a loop. The helices 
mediate dimerization with homologous or heterologous bHLH proteins. The adjacent basic 
region fits in the major groove of the DNA and is required for DNA binding to the E-box 
hexamer CANNTG (Murre et al., 1989a; Murre et al., 1989b). The nucleotides of this 
DNA recognition motif vary in different subfamilies of bHLH transcription factors, which 
are grouped on the basis of closer sequence similarities in the bHLH domain. Subfamilies 
of bHLH proteins are, for example, the atonal family, including the Math proteins, the olig 
family with the olig factors, the achaete-scute family, which comprises the Mash proteins, 
the NeuroD family with NeuroD- and Math factors and the neurogenin family, which 
contains the neurogenin (Ngn) proteins (reviewed by Bertrand et al., 2002). 
Zinc finger proteins consist of a motif in which either four cysteine residues or two 
cysteine and two histidine ligands coordinate a zinc ion (C2-C2 type or C2-H2 type). In most 
proteins, this domain is present in multiple copies as regular tandem arrays with invariant 
cysteine and histidine residues in each repeat. Every single motif hence forms an 
independently folded structural domain organized around a zinc ion, which is essential for 
correct folding. The polypeptide fold consists of a helix and two ß-strands that are arranged 
in a hairpin structure (Lee et al., 1989) see also fig.3-4 in chapter 3). The zinc finger 
domain mediates specific DNA recognition and -binding of transcription factors and is also 
used in protein-protein interactions (Berg, 1990; reviewed by Bertrand et al., 2002; Evans 
and Hollenberg, 1988; Miller et al., 1985). The vast majority of zinc finger proteins can be 
classified as Krüppel-like on the basis of a shared, highly conserved sequence stretch, the 
H/C-link, which connects consecutive finger repeats (Schuh et al., 1986). 
Homeobox transcription factors were originally proposed to constitute a multigene 
family in Drosophila melanogaster by the group of Walter Gehring in the biocenter in 
Basel who reported that these homeotic genes reside in distinct chromosomal gene 
complexes (the Hox-clusters) and function in the specification of body segments during 
embryonic development (Kappen et al., 1993; McGinnis et al., 1984; Moretti et al., 1994; 
reviewed by Scott et al., 1989). Genes that code for members of the homeodomain family 
of transcription factors contain a common sequence of about 180 bp (the homeobox) that 
encodes a DNA-binding protein sequence known as the homeodomain. The structure of the 
61-amino acid homeodomain is constituted by three α-helices (helix-turn-helix) and is 
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highly conserved across species (reviewed by Kappen and Ruddle, 1993). Nevertheless, 
apart from this domain, Hox proteins are highly diverged and can be grouped into 
subclasses upon closer sequence similarity (McGinnis et al., 1984; Scott et al., 1989). 
ETS-domain transcription factors share a highly homologous 80-90-amino acid DNA-
binding domain, the ETS domain, which was first discovered in oncogenes cloned from 
retroviruses (Karim et al., 1990). In addition to directing specific protein-DNA 
interactions, the ETS domain also mediates protein-protein interactions (Nye et al., 1992; 
Sharrocks, 2001; reviewed by Wasylyk et al., 1993). Outside the conserved DNA-binding 
domain, ETS factors reveal a pronounced divergence and can be grouped into subclasses 
based on additional homologous regions unique for particular members of the ETS family 
(Janknecht and Nordheim, 1993; Wasylyk et al., 1993) 
Forkhead proteins share a winged helix DNA-binding domain of about 100 amino acids, 
which folds into a variant of the helix-turn-helix motif and is made up of three α-helices 
and two characteristic large loops, or “wings” (Kaestner et al., 2000; Lim et al., 1997). In 
1998, a standardized nomenclature for all chordate winged helix / forkhead transcription 
factors was introduced and Fox (Forkhead box) was adopted as the unified symbol for 
these proteins (Kaestner et al., 2000). Apart from the conserved DNA-binding domain, Fox 
proteins are highly divergent and can be sub-classified in 15 subclasses (Kaestner et al., 
2000). 
1.2.2 Transcription factors are key regulators during nervous system 
 development and regeneration 
Transcription factors are differentially expressed in a developmental, tissue-specific or 
stimulus-inducible manner. Descriptions of discrete expression patterns of transcription 
factors during nervous system development and analyses of mutant phenotypes reveal the 
regulatory role of region- and cell-type specific transcription factors in morphogenesis and 
differentiation of the vertebrate nervous system (reviewed by Bang and Goulding, 1996). 
The neurogenic bHLH transcription factor Nex1/Math-2, for example, displays its peak 
expression during brain development when neurite outgrowth and synaptogenesis are 
highly active and is a key activator of the growth-associated GAP-43 gene (Uittenbogaard 
et al., 2003). Knockout experiments, in which the expression of distinct transcription 
factors was disrupted, have pointed out important roles transcription factors play during 
nervous system development. CREB null mice, for example, display defects in axonal 
projections within two major brain commissures (Lonze and Ginty, 2002), deletion of 
ATF-2 (=CREB2) results in a disturbed organization of the cerebellum with reduced 
numbers of Purkinje cells (reviewed by Herdegen and Leah, 1998). Disruption of the zinc 
finger protein Krox-20 leads to the loss of two hindbrain rhombomeres and some 
motoneurons and is accompanied by insufficient myelination and misrouting of growing 
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axons (Herdegen and Leah, 1998). Brn-3a knockout mice exhibit enhanced neuronal cell 
death and severe differentiation and migration defects in sensory and motor neurons 
(McEvilly et al., 1996; Xiang et al., 1996). Moreover, the Emx2 homeodomain protein, 
whose function was likewise revealed by deletion of the gene, is essential for terminal 
differentiation of granular cells of the dentate gyrus and plays a role in neuronal migration 
and formation of proper axonal connections in hippocampal, olfactory as well as thalamo-
cortical circuits (Mallamaci et al., 2000; Savaskan et al., 2002; Yoshida et al., 1997).  
Many transcription factors are differentially regulated in a temporal and spatial fashion in 
the brain during postnatal development, which emphasizes their role during CNS 
development. The fos-proteins, for example, are downregulated in brain during 
development (Alcantara and Greenough, 1993), as also are two short isoforms of the brain 
basic helix-loop-helix factor 1 (Kawakami et al., 1996). As dividing progenitor cells 
differentiate into distinct phenotypes, there is a co-ordinated activation and repression of a 
variety of genes, which are under the control of complex regulatory networks of 
transcription factors. These are first induced by concentration gradients of diffusible 
signals such as sonic hedgehog (shh) or bone morphogenetic protein (bmp) which 
progenitor cells are able to translate into expression of a specific set of transcription factors 
(Gurdon and Bourillot, 2001). By acting in a sequential fashion and regulating downstream 
target genes, transcription factors expressed in progenitor cells play an important role in 
determining the cell’s fate (reviewed by Jurata et al., 2000; Lee and Pfaff, 2001). 
Similarly, a set of transcription factors in postmitotic neurons is responsible for 
determination of the neurons mature phenotype by regulating the expression of terminal 
differentiation genes (reviewed by Lee and Pfaff, 2001). The POU-domain transcription 
factor unc-86, for example, is necessary for the synthesis and packaging of serotonin and 
plays a role in neurite outgrowth in specific serotonergic neurons in C.elegans (Sze et al., 
2002). The ETS-transcription factor Pet-1 is an additional marker of central serotonergic 
neurons and activates the transcription of several genes, whose expression is characteristic 
of the serotonergic neuronal phenotype (Hendricks et al., 1999).  
In C.elegans, a sequential action of transcription factors is found in motor neurons: they 
express a Hox transcription factor that regulates the expression of two further transcription 
factors of the POU- and zinc finger family, which in turn control neuronal differentiation 
processes, e.g. neuronal migration (Baum et al., 1999). Likewise, in the developing spinal 
cord and telencephalon of vertebrates, progenitor cells residing in defined progenitor 
domains give rise to different types of cells. Progenitor domains are characterized by 
differential expression of unique combinations of homeodomain transcription factors such 
as the Pax-, Emx- or LIM homeobox (Lhx) proteins and bHLH transcription factors, e.g. 
Olig2, Mash1 and the proneural neurogenin (Ngn) proteins (reviewed by Lee and Pfaff, 
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2001; O'Leary and Nakagawa, 2002; Schuurmans and Guillemot, 2002; Shirasaki and 
Pfaff, 2002; Tsuchida et al., 1994). If this patterned expression of transcription factors is 
perturbed, progenitor cells give rise to different types of cells and exhibit changes in their 
migration pattern and neuronal axon pathfinding, which reveals, that these transcription 
factors are essential for arealization, cell fate determination, neurogenesis and neuronal 
subtype specification with the ability to select specific axon pathways (Nakagawa and 
O'Leary, 2001; reviewed by Schuurmans and Guillemot, 2002; Sharma et al., 2000; 
Sharma et al., 1998). Distinct classes of neurons thus can be recognized based on their 
expression profiles of transcription factors (Ericson et al., 1997; Moran-Rivard et al., 2001; 
Sharma et al., 1998; Tanabe et al., 1998). In the same way, neurogenesis and neuron 
subtype specification in the developing retina are regulated by a highly defined expression 
of proneural bHLH proteins (reviewed by Vetter and Brown, 2001).  
Furthermore, each developing neuron has been genetically programmed to be able to sense 
its unique pathway-specific guidance cues in order to reach its appropriate target regions 
(reviewed by Eisen, 1994). This intrinsic capacity is also conveyed by the expression of 
certain transcription factors (reviewed by Pfaff and Kintner, 1998). In Drosophila 
interneurons, the gene apterous, which codes for a LIM-homeodomain protein, has been 
shown to control pathway selection and axon fasciculation (Lundgren et al., 1995). The 
zebrafish homeobox gene Noi is required for commissural axon pathway formation across 
the midline of the diencephalon and might exert this function by regulating the expression 
of axon pathfinding molecules such as the netrins (Macdonald et al., 1997). In vertebrates, 
the Vax1 homeodomain transcription factor is expressed by midline glial cells of the CNS 
and is implicated in commissural axon crossing at the midline by activating the expression 
of guidance cues such as netrin or the receptor protein-tyrosine kinases EphB2 and EphB3 
(reviewed by Lemke, 2001). Pax-6 is required for proper pathfinding of the postoptic 
commissural tract (Mastick et al., 1997) and certain LIM-homeodomain proteins are 
important for axonal pathfinding of cranial motor nerves during development of the 
brainstem (Varela-Echavarria et al., 1996). Two homeodomain proteins En-1 and En-2, 
homologues of the Drosophila segment polarity gene engrailed, as well as two forkhead 
transcription factors are involved in the establishment of a topographical retinotectal map 
in the developing chick (Itasaki and Nakamura, 1996; Yuasa et al., 1996). The ETS factors 
ER81 and PEA3 control establishment of functional sensory-motor circuitry in the 
developing spinal cord (Arber et al., 2000; Lin et al., 1998).  
Many transcription factors are induced in response to neurotrophins such as NGF or 
BDNF, for example PAX family members (Kioussi and Gruss, 1994) and CREB (reviewed 
by West et al., 2002). The early growth response gene, Egr1, is also induced in PC12 cells 
upon stimulation with NGF, which elicits differentiation of these cells into neuron-like 
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cells (Milbrandt, 1987; Sheng and Greenberg, 1990). Recently, a leucine zipper 
transcription factor was identified, which is induced following NGF stimulation and 
regulates neurite outgrowth of immature telencephalic neurons (Torocsik et al., 2002).  
Evidence has been attained that transcription factors are also involved in the cellular 
response to nervous system injuries as some of them are induced after axonal lesions, for 
instance the transcriptional regulators that belong to the group of immediate early genes 
(IEGs). c-Jun, as one example, is strongly increased in dorsal root ganglion cells and motor 
neurons after sciatic nerve lesion (Jenkins and Hunt, 1991). In rat retinal ganglion cells, a 
significant increase of Jun and KROX proteins and decrease of the CREB transcription 
factor occur transiently after optic nerve lesion and parallel axonal sprouting (Herdegen et 
al., 1993). In addition, Robinson et al. demonstrated that c-Jun is upregulated in 
regenerating but not in non-regenerating retinal ganglion cells after transection of the optic 
nerve with and without an implanted peripheral nerve graft, respectively (Robinson, 1995). 
c-Jun and JunB are strongly induced in facial motor neurons after peripheral transection of 
the facial nerve (Haas et al., 1993) and in medial septal neurons after axotomy of the 
septohippocampal projection (Haas et al., 1996). Jun proteins and, to a lesser extent, Krox-
24, are also induced after transection of the rat medial forebrain bundle in the 
corresponding affected neurons, most likely due to an interruption of the axonal transport 
(Leah et al., 1993). The limited regeneration of CNS axons into peripheral nerve grafts can 
be correlated with the rapid loss of c-Jun expression in Schwann cells following exposure 
to the CNS environment (Vaudano et al., 1996). Activating transcription factor 3 (ATF3), 
which can form heterodimers with c-Jun, is induced after peripheral nerve axotomy in 
concert with c-Jun in sensory DRG neurons and motoneurons of the spinal cord (Tsujino et 
al., 2000). Nevertheless, despite the relationship between the expression of injury-induced 
genes, the so-called cell body response, and the regenerative potential of lesioned neurons, 
the precise role of such genes in axon growth is still unclear, if not controversial, because 
some of them can also induce cell death (reviewed by Herdegen et al., 1997; Vaudano et 
al., 1998). Moreover, c-Jun induction after axotomy is age-independent in medial septal 
neurons and occurs in young, regenerating as well as mature, growth-resistant 
septohippocampal neurons (Haas et al., 1998). It was demonstrated that the elevation of 
IEG products including c-Jun, which occurs in response to convulsant stimuli, is not 
obligatory for reactive mossy fiber sprouting in the hippocampus (Nahm and Noebels, 
1998). Although the role and regulation of c-Jun in axotomized neurons is not yet clear, 
some other molecules involved in the regenerative response have been identified that might 
be regulated by c-Jun. The growth-associated molecule GAP-43, for example, is co-
expressed in parallel with c-Jun in regenerating neurons after nerve transection (Caroni, 
1997; Haas and Frotscher, 1998; reviewed by Herdegen et al., 1997).  
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Other transcription factors were also shown to be implicated in lesion-induced processes. 
The class III POU-domain transcription factor Brn-3a, for example, which plays a role in 
the survival of sensory neuronal populations during development, can enhance neuronal 
survival after peripheral nerve injury by inducing the expression of anti-apoptotic proteins, 
e.g. bcl-x (L) (Smith et al., 2001). The POU-domain transcription factor Oct-6 (also known 
as Scip or Tst-1) is a major regulator of Schwann cell differentiation and myelination 
during peripheral nerve development and also during nerve regeneration (Mandemakers et 
al., 2000), is re-expressed after injury and can accelerate axonal regeneration in transgenic 
mice (Gondre et al., 1998; Scherer et al., 1994). Oct-2 expression is transiently increased 
after peripheral axotomy of sensory neurons and therefore might also be important for 
regeneration (Begbie et al., 1996). In tailed amphibia that are capable of regenerating 
spinal cord axons after nerve transection or tail amputation, the Sox1 homeobox 
transcription factor is upregulated following lesion and parallels spinal cord regeneration 
(Ferretti et al., 2003). 
In summary, transcription factors are highly regulated during nervous system development 
and after nerve injuries and are involved in various aspects of neuronal development, e.g. 
the generation of appropriate neuronal cell types, establishment of specific neuronal 
connections and determination of soma positions, axonal projection patterns, dendritic 
morphologies, expression of specific ion channels, neurotransmitter receptors and 
appropriate neurotransmitters (Edlund and Jessell, 1999; reviewed by Jessell, 2000; 
Shirasaki and Pfaff, 2002). After nervous system lesions, some transcription factors are 
differentially regulated and changes in expression patterns could be correlated with 
regenerative processes in a few cases, although precise functions of transcription factors 
after lesions remain to be elucidated. Yet, the knowledge about gene regulation after 
nervous system lesions is still quite poor. Altogether, transcription factors constitute an 
important molecule class with crucial regulatory functions during nervous system 
development that are essential for the proper functioning of the mature brain and might be 
re-activated after nerve injuries in order to trigger regeneration. 
1.3 Aim of the present studies 
1.3.1 Identification of transcription factors highly expressed in CNS 
 neurons during establishment of axonal connections 
As not much is known about the signals that control and define a neuron’s growth state, the 
major interest of the studies presented here focused on the regulation of axonal outgrowth 
of CNS neurons during neuronal development and differentiation. In order to elucidate the 
molecular mechanisms that underlie developmental fiber outgrowth, the studies aimed at 
the identification of molecules, which are highly expressed during axonal outgrowth and 
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differentiation and thus might be potential regulators of the neuronal growth state. Two 
brain regions, the cerebellum and entorhinal cortex, were previously examined in slice 
culture models and their axon growth behaviour is well described during neuronal 
maturation and after fiber transection in vivo and in vitro. The studies revealed the time 
span of massive axonal outgrowth of cerebellar Purkinje neurons and entorhinal pyramidal 
cells, therefore these two CNS regions were chosen for examination of the gene expression 
patterns of axon-extending CNS neurons during neuronal differentiation. In Purkinje 
neurons, maximal axonal outgrowth occurs from late embryonic development until the first 
postnatal days, in entorhinal pyramidal neurons, growth-competence is high at birth and in 
the first postnatal week. At later time points of development, the potential for axon growth 
decreases strongly until it is completely lost. Based on these studies, a first approach was 
set up, in which it was searched for molecules involved in regulating axonal outgrowth in 
rat cerebellum at E18 and entorhinal cortex at P0.  
The search focused on a certain group of molecules, the transcription factors, as they are 
potential regulators of many downstream target genes and control several processes during 
neuronal development. Yet, very little is known about transcription factor expression 
during axonal outgrowth of cerebellar Purkinje cells or pyramidal cells of the entorhinal 
cortex. As the expression of axonal growth-associated genes might be modulated in 
response to changes in the complement of regulatory proteins present in a cell, it is of great 
interest to identify such molecules, e.g. transcription factors that might function as critical 
regulators of different aspects of axon growth. Assuming that regeneration-related changes 
in gene transcription in CNS neurons might reflect expression programs during the period 
of axonal outgrowth during development, transcription factors might have important 
regulatory functions during both, neuronal development as well as axonal regeneration. 
The aim of the first approach of the present studies was, therefore, to identify members of 
various transcription factor classes in rat cerebellum at E18 and entorhinal cortex at P0, the 
time of extensive axon outgrowth, by degenerative PCR. This method is based on the fact 
that transcription factors of a certain family share a highly conserved DNA-binding 
domain, which allows the identification of new family members by PCR using degenerate 
oligonucleotides that are specific for the most conserved region. The conserved DNA-
binding domains of the POU-, homeobox- (Hox), basic helix loop helix- (bHLH), zinc 
finger-, forkhead- and ETS- transcription factor families are well described and their 
consensus sequences were therefore taken as a basis for the generation of degenerate 
oligonucleotides. In the past, transcription factors of various transcription factor families 
were cloned by the method of degenerate PCR from various tissues and these studies were 
helpful for the design of degenerate PCR primer sequences (Agata et al., 1998; Chuaqui et 
al., 1997; Dovat et al., 1998; Furukawa et al., 1996; Gorski et al., 1994; POU: He et al., 
1989; Hromas et al., 1993; Jehn et al., 1994; FKH: King and Moore, 1994; ETS: Lopez et 
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al., 1994; Mesa et al., 1996; HOX:Moretti et al., 1994; Murtha et al., 1991; Zinc finger: 
Pellegrino and Berg, 1991; bHLH: Peyton et al., 1996; Singh et al., 1991; Walters et al., 
1997). 
In summary, applying PCR with degenerate primers for various transcription factor 
families onto cDNA from rat cerebellum at E18 and rat entorhinal cortex from P0 should 
allow the isolation and identification of transcription factors from two CNS regions at the 
time when massive axonal outgrowth occurs.  
For several reasons, which are outlined in section 3.1.5, this approach turned out not to be 
promising. Another approach was therefore set up, which was methodically different but 
followed a similar goal. 
1.3.2 Identification of developmentally regulated genes by Suppression 
 Subtractive Hybridisation (SSH) 
For the second approach, a more general strategy was used. So far, the main concern was 
to identify molecules, which are highly expressed during developmental fiber outgrowth in 
the CNS and therefore might regulate the intrinsic growth state of a developing neuron. As 
embryonic CNS neurons are well capable of elongating and regenerating their axons but 
loose this ability during maturation, growth-associated molecules possibly become 
downregulated in later stages of development after the completion of axon tract formation. 
This question was taken into consideration for planning the next experimental procedures. 
Like the differential display method or microarray analyses, the technique of suppression 
subtractive hybridisation allows the comparison of two distinct mRNA-populations and the 
identification of genes primarily expressed in one of both populations. By applying SSH, 
genes that are equally expressed in any two populations are subtracted and thereby sorted 
out from both groups. Only those genes, which are principally expressed in just one of the 
two populations, are enriched and are available for further analysis. SSH thus seemed to be 
a valuable tool to examine developmental changes in gene expression patterns of CNS 
neurons.  
In order to identify genes, which exhibit an abundant expression in developing, axon-
extending CNS neurons but which are only weakly expressed in mature neurons that have 
completed fiber growth and lack regenerative long-distance growth, the second approach 
of the present studies aimed at the identification of genes, which are differentially 
expressed in Purkinje neurons and entorhinal pyramidal cells, respectively, during neuronal 
maturation. As pointed out in 1.1.3, previous experiments with slice cultures from 
cerebellum and entorhinal cortex had extensively examined the growth competence of 
Purkinje neurons and entorhinal pyramidal cells and their dependency on maturation of the 
respective neurons. The decrease in regenerative capability was shown to occur after the 
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first postnatal week around P7 in cerebellar Purkinje cells and from about P10 in entorhinal 
pyramidal neurons. These studies thus served as a basis to determine the time points for 
subtraction approaches in rat cerebellum and entorhinal cortex, in which developmental 
changes of gene expression patterns were examined. Accordingly, P0 and P10 were 
defined as the developmental stages to be compared in entorhinal cortex, with P0 
representing the age of growth-capability and P10 the stage of growth-incapability. For 
comparison of expression patterns during the change of growth-competence in Purkinje 
neurons, developmental stages E18 and P35 were chosen. A time point later than P7 was 
preferred for examination of growth-incapable cerebellar neurons as other cerebellar 
neurons, e.g. the granule cells, arise much later during development and are still born in the 
third week after birth. It was assumed that at P35 all axonal fiber bundles should have 
established in the rat cerebellum. Thus, in the cerebellar approach, transcripts present at 
P35 were planned to be subtracted from transcripts present at E18, thereby identifying 
genes which are predominantly expressed in the late embryonic stage, when massive axon 
outgrowth of Purkinje neurons occurs in vivo and when regenerative growth of Purkinje 
cell axons over long distances is possible in vitro. Similarly, in order to compare the 
transcriptional activity of axon-extending entorhinal cortex neurons with mature, growth-
incapable EC-pyramidal neurons, transcripts from rat entorhinal cortex at P10 were 
planned to be subtracted from transcripts from entorhinal cortex at P0, resulting in the 
enrichment of genes which are predominantly expressed around birth when perforant path 
fibers grow towards their target, the granule cells in the dentate gyrus.  
In brief, both subtraction approaches with maturing Purkinje cells and entorhinal pyramidal 
cells, respectively, should result in the identification of genes which are highly expressed 
during axonal outgrowth of these neurons in the rat brain but which are downregulated 
thereafter and are, if at all, only weakly expressed in the adult CNS when no axon growth 
over long distances occurs anymore.  
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2 Materials and Methods 
Buffers and solutions used for the following protocols are described separately in section 
2.15. 
2.1 Polymerase chain reaction (PCR) 
PCR was performed according to a standard protocol, unless other cycling-conditions are 
delineated in the text. 
Standard-PCR: initial denaturation step: 94°C – 2 min. 
 denaturation: 94°C – 45 sec. 
 primer-annealing: 55°C – 30 sec. 30x 
 elongation: 68°C – 45sec. 
 final elongation step: 68°C – 7 min. 
Annealing and elongation temperatures as well as duration of cycling steps and number of 
cycles were adapted to the applied oligonucleotide primers (see 2.13.5), DNA-polymerases 
and DNA-templates. Elongation with the Taq- or PWO- DNA-polymerase was performed 
at 72°C. A hot start was performed by first heating the samples for 8 min. at 95°C and then 
adding the polymerase directly to each tube. Amplification with the Advantage 2 
Polymerase Mix, which includes a hot start, was performed at 68°C. Any difference to the 
standard PCR is indicated in the accordant text part in the results section (chapter 3). 
2.2 Purification, precipitation and quantification of DNA 
DNA was purified with the PCR-Purification Kit or Gel-Extraction Kit from Qiagen 
according to the manufacturer’s instructions. Precipitation was carried out with sodium 
acetate and ethanol following the standard protocols from (Sambrook and Russell, 2001), 
section A8.12, and DNA was then quantified by measuring the optical density in a UV-
spectrophotometer at a wavelength of 260 nm. 
2.3 Fluorescent DNA sequencing 
Capillary sequencing of cloned DNA was performed with the ABI PRISM 310 genetic 
analyser using the ABI PRISM BigDye Terminators Cycle Sequencing Ready Reaction 
Kit. The DNA sample to be sequenced was amplified by PCR with the Terminator Ready 
Reaction Mix. The amplification product was then precipitated and the pellet resuspended 
in 17 µl Template Suppression Reagent and applied for capillary sequencing after 
denaturation at 95°C for 5 min. Sequence results were analysed with the program 
Chromas, version 2.22, Technelysium (free trial at http://www.technelysium.com.au/ 
chromas.html). 
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2.4 Digestion of DNA with restriction endonucleases 
Restriction digestion of DNA-fragments and plasmid vectors was applied for subsequent 
cloning or linearisation of circular plasmid DNA for further riboprobe-synthesis. 1µg of 
DNA was digested with 5-10 units of enzyme for 2 hours at the indicated temperature. The 
enzyme volume should not exceed 1/10 of the total reaction volume. 
2.5 Electrophoretic separation of nucleic acids 
DNA was supplied with 1x DNA sample buffer and separated on a 1-2,5% agarose gel in 
1xTAE-buffer. Ethidium bromide was incorporated in the agarose gel (1,5 µl of a stock 
solution in 150 ml gel solution) so that DNA bands were directly visible under UV-
illumination. For separation of RNA, electrophoresis tanks and gel chambers were 
incubated with 3% H2O2 before use. RNA was diluted 1:1 with 2x RNA sample buffer 
containing ethidium bromide and denatured at 85°C for 5 to 10 min. After adding 6x RNA 
loading buffer, samples were separated on a formaldehyde-containing 1-1,5% agarose gel 
in 1x MOPS-buffer. For preparation of gels, agarose from Gibco-BRL (Invitrogen) was 
used. 
2.6 Cloning 
2.6.1 Plasmids 
pCR 2.1-TOPO cloning vector Invitrogen 
pCR II-TOPO cloning vector Invitrogen 
pPCR-Script Cam SK(+) cloning vector  Stratagene 
pBKSII-/Tst-1 (inserted POU-transcription factor Tst-1) M. Wegner, ZMNH, Hamburg 
2.6.2 Bacterial strains 
TOP10 One Shot Chemically Competent E.coli cells  Invitrogen 
Epicurian Coli XL10-Gold Kan ultracompetent cells  Stratagene 
Both bacterial strains were used for amplification of recombinant DNA in form of plasmid-
vectors. Selection occurred by addition of 100 µg/ml ampicillin or 10-20 µg/ml 
chloramphenicol, depending on the resistance gene in the particular plasmid. Broths were 
prepared as indicated in the list of frequently used buffers and solutions (section 2.15). 
2.6.3 Insertion of DNA into plasmids 
Linearised plasmid DNA was treated with shrimps alkaline phosphatase according to the 
manufacturer’s instructions in order to avoid re-ligation of vector ends in ligation assays. 
PCR cDNA fragments were added to linearised and dephosphorylated vector DNA in a 2:1 
molar ratio and ligated over night with T4 DNA-ligase following the standard protocol 
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described in (Sambrook and Russell, 2001), section 1.87. Alternatively, PCR fragments 
were ligated in 5-30 min. into pCR-TOPO cloning vectors with the TOPO TA cloning Kit 
according to the supplier’s instructions.  
2.6.4 Bacterial transformation 
Competent bacterial cells were transformed chemically by heat shock (30 sec. at 42°C), 
grown for 1 hour in broth without antibiotic and then plated on agar plates containing 
40µg/ml X-gal and the adequate antibiotic (20 µg/ml chloramphenicol and 100 µg/ml 
ampicilline, respectively). After incubation over night at 37°C, bacterial colonies could be 
selected by blue/white-screening. Insert-containing clones were white, whereas re-ligated 
vector clones without insert were blue. 
2.6.5 Preparation of Plasmid DNA 
Plasmid DNA, amplified in bacteria, was isolated and prepared with Miniprep- or 
Midiprep- Kits (Qiagen), corresponding to the expected quantities of plasmid DNA. 
2.7 RNA Extraction and Purification 
Total RNA was isolated from rat brain tissues (see also 2.14) using the RNeasy Mini Kit 
(Qiagen). Animal tissue was shock frozen in liquid nitrogen and disrupted and 
homogenized with a rotor-stator homogeniser in the presence of a denaturing guanidine 
isothiocyanate-containing buffer according to the manufacturer’s instructions. Genomic 
DNA was digested with DNase I (Qiagen) as described in the RNeasy Mini Kit 
instructions. 10 mg of tissue yielded about 10-30 µg total RNA, depending on the 
developmental stage of the rats used. RNA quality was controlled on a denaturing agarose 
gel (see also 2.5); purity and concentration were determined by spectrophotometry at a 
wavelength of 260 nm. 
2.8 Suppression Subtractive Hybridization (SSH) 
The method of SSH, which enables researchers to compare two populations of mRNA and 
obtain clones of genes that are expressed in one population but not in the other, was 
originally described by (Diatchenko et al., 1996). In brief, mRNAs of both populations are 
converted into cDNA, hybridised with one another and the hybrid sequences removed. 
Consequently, the remaining unhybridised cDNAs represent genes that are expressed in 
one population but are absent from the other. In a following step, the differentially 
expressed sequences can be selectively amplified by PCR. The samples that were 
compared in the present analysis were derived from RNA from rat cerebellum at two 
developmental stages: embryonic day 18 (E18), corresponding to the time point of 
maximal axonal outgrowth of cerebellar Purkinje cells, and postnatal day 35 (P35), when 
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axonal outgrowth of all cerebellar neurons is completed (approach “A”). A second 
approach (approach “B”) was similarly performed with RNA from rat entorhinal cortex at 
P0, when outgrowth of entorhinal fibers to the dentate gyrus of the hippocampus is 
maximal, and P10, when axonal outgrowth ceases. Complementary DNAs (cDNAs) were 
synthesized from 1 µg total RNA using the SMART PCR cDNA Synthesis Kit, and 
subtractive hybridisation was performed with the PCR-Select cDNA Subtraction Kit. 
cDNAs derived from the later stage of development, the reference cDNAs, were 
considered the “driver” pool, cDNAs derived from the earlier stage of development, which 
contained specific, differentially expressed transcripts, the “tester” pool. 
cDNA-population 
of the subtraction 
approach 
Rat 
brain tissue 
developmental 
age 
characteristics 
 
“Tester” A cerebellum Embryonic day 18 
Maximal outgrowth 
of Purkinje cell 
axons 
“Driver” A cerebellum Postnatal day 35 
Axonal outgrowth of 
all cerebellar 
neurons completed 
 
“Tester” B entorhinal cortex Postnatal day 0 
Maximal outgrowth 
of entorhinal 
perforant path fibers
“Driver” B entorhinal cortex Postnatal day 10 
Entorhino-
hippocampal 
pathway formation 
completed 
Both cDNA samples were digested with the restriction endonuclease Rsa I to generate 
shorter, blunt-ended double-stranded cDNA fragments. To select for transcripts highly 
expressed in the “tester” population but strongly downregulated in the “driver” population, 
PCR adaptors were ligated to the “tester” pool, which then was hybridised with excess 
cDNAs from the “driver” pool. After hybridisation, suppression PCR with primers specific 
for the ligated “tester”-adaptors was applied for selective amplification of differentially 
expressed transcripts, present in the “tester” pool (cerebellum at E18 and entorhinal cortex 
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at P0, respectively) but not present or expressed to a much lower level in the “driver” pool 
(cerebellum at P35 and entorhinal cortex at P10, respectively). Amplified cDNA sequences 
were then ligated into the pUC-derived TOPO TA-cloning vector pCR II-TOPO and 
transformed into E.coli bacteria. Subtracted clones were randomly picked, miniprepped 
and sequenced by capillary electrophoresis. Finally, all sequences were checked for 
homology to known genes in GenBank, EMBL, DDB and PDB databases using the 
following computer programs: BlastN and BlastP from the National Center for Biological 
Information, NCBI (www.ncbi.nlm.nih.gov/blast/), and NIX and PIX from the UK Human 
Genome Mapping Project Resource Centre (www.hgmp.mrc.ac.uk/Registered/Menu/). For 
sequences that gave significant similarities only to Expressed Sequence Tags (ESTs), 
overlapping EST-sequences were searched in the EST-divisions of GenBank, EMBL and 
DDB databases. Overlapping fragments were then compiled with the program Gene 
Runner (Version 3.00, Hastings Software, Inc.) and again used for homology searches to 
known genes. 
2.9 In vitro transcription 
Templates for in vitro transcription were generated either by PCR-amplification of DNA-
sequences inserted into plasmids using T7- and sp6- promotor primers or by restriction 
digestion of plasmids containing the insert of interest. Single-stranded DIG-labelled cRNA 
probes were synthesized with T7- and sp6- RNA-polymerases, respectively, using a 
Digoxigenin RNA labelling mix (Roche) according to the manufacturer’s protocol. DNA 
was digested with DNase I (Catalys) after completed riboprobe synthesis. After 
precipitation, DIG-labelled RNA probes were resuspended in ddH2O and RNase inhibitor 
was added (2-5 U/µl suspension volume). The concentration of synthesized riboprobe was 
estimated on a denaturing formaldehyde-containing agarose gel in comparison with 
defined quantities of a DIG-labelled control RNA (Roche). 
2.10 Northern Blot analysis 
5 µg of total RNA were size-fractionated on a 1,5% denaturing formaldehyde-agarose gel. 
After washing the gel 2 times in 20x SSC, a capillary blot was set up as previously 
described (Sambrook and Russell, 2001, section 7.35), and RNA was blotted onto a 
positively charged Nylon membrane (Roche). After UV-irradiation, the blot was incubated 
for 1h at 68°C in prehybridisation buffer. For hybridisation, 300 ng/ml riboprobe was 
added and the blot was incubated overnight at 68°C. The next day, the blot was washed 
twice in washing buffer 1 at room temperature for 15 min., followed by a washing step in 
the same buffer at 68°C for 30 min. Thereafter, the blot was washed twice in washing 
buffer 2 at 68°C for 30 min, blocked in 1% Blocking solution (Roche) for 45 min. at room 
temperature and incubated 1h with anti-DIG-alkaline phosphatase-conjugated Fab 
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fragments (Roche, 1:10000) at room temperature. Prior to detection, the blot was washed 3 
times with washing buffer 3. Chemiluminescent detection was performed with CSPD-
substrate for alkaline phosphatase (Roche) according to the manufacturer’s instructions and 
light emission was recorded on an X-ray film. To re-hybridise blots with another 
riboprobe, chemiluminescence was removed with water and blots were stripped twice in 
0,2% SDS just before boiling for 10 min. After washing in washing buffer 4 for 10 min., 
blots were prehybridised and hybridised as before. Any changes in the performance are 
specified in the appropriate text part in chapter 3. 
2.11 In situ-Hybridisation 
Embryonic and neonatal Sprague-Dawley rats were decapitated, their brains removed, 
rapidly frozen in tissue freezing medium and kept at –80°C until use. Starting at 5 weeks of 
age, Sprague-Dawley rats were anaesthetized with 0,1 ml/100 g body weight vetanarcol 
before decapitation. In situ hybridisation was performed as described previously by 
Schaeren-Wiemers and Gerfin-Moser with slight modifications: 20 µm-frozen sections 
were cut on a cryostat, mounted on superfrost plus slides and dried on a hot plate at 45 °C 
for 1h (Schaeren-Wiemers and Gerfin-Moser, 1993). Sections were then incubated in 
fixative for 10 min., washed 3 times in PBS and afterwards treated with acetylation 
solution for 10 min. Sections were then again washed 3 times in PBS. Prior to 
hybridisation, sections were preincubated for 1h at room temperature in prehybridisation 
buffer. Hybridisation was carried out overnight in prehybridisation buffer with 500 ng/ml 
of either antisense or sense digoxigenin-labelled riboprobe at 72°C in probe-clip press-seal 
incubation chambers (Sigma). Tissue sections were subsequently incubated in 0,2x SSC at 
68°C for 1h and rinsed with 0,2x SSC at room temperature thereafter. Following a short 
wash in Maleic acid buffer, sections were blocked in 1% blocking solution (Roche) for 1h 
at room temperature, shortly rinsed in maleic acid buffer and incubated with anti-DIG-
alkaline phosphatase-conjugated Fab fragments (Roche, 1:5000) for 1h at room 
temperature. After a short incubation in DIG-detection buffer, colour detection of 
transcripts was carried out upside down in DIG-colour reaction solution. After stopping the 
enzymatic reaction in TE-buffer, sections were cover slipped with Kaiser’s Glycerine 
gelatine. Cresylviolet staining was performed after fixation and PBS washes, sections were 
cover slipped with Eukitt (O.Kindler GmbH, Freiburg, Germany). Stained brain sections 
were digitally photographed with a Spot camera (Diagnostic Instruments) mounted on an 
Olympus AX70 microscope. Any changes in the performance are specified in the 
appropriate text part in chapter 3. 
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2.12 Equipment 
Cryostat (CM1900) Leica 
ABI PRISM 310 genetic analyser (capillary sequencer) Applied Biosystems 
Balances Ohaus and Mettler-Toledo 
UV-spectrophotometer Applied Biosystems 
Electrophoresis tanks and power supplies Owl 
Power supplies Apelex, BioRad 
Centrifuges (Biofuge stratos, Megafuge 1.0, Biofuge pico) Heraeus 
Bacterial Incubator Heidolph 
Hybridisation oven Heraeus 
Thermomixer Eppendorf 
Gel Documentation System Intas 
Microscope (AX70) Olympus 
Camera Diagnostic Instruments Inc. 
Rocking platfom Heidolph 
Ultra-Turrax T50 IKA 
Magnetic Stirrer IKA 
PCR-Mastercycler gradient Eppendorf 
GeneAmp PCR system 2400 Applied Biosystems 
2.13 Consumables 
2.13.1 Chemicals 
Unless otherwise annotated in the text, chemicals were obtained from Merck, Fluka, Axon 
Lab, Sigma, AppliChem and Roth. 
2.13.2 Enzymes 
Restriction endonucleases Roche 
Shrimps alkaline phosphatase Roche 
T4 DNA-ligase Roche 
RNase-inhibitor Invitrogen 
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T7-RNA-polymerase Roche 
Sp6-RNA-polymerase Roche 
PowerScript Reverse Transcriptase Clontech 
Expand Reverse Transcriptase Roche 
PWO DNA-polymerase Roche 
Taq DNA-polymerase Roche 
Advantage 2 Polymerase Mix Clontech 
DNase I, RNase-free Catalys / Promega and Qiagen 
2.13.3 Materials 
Nylon membranes, positively charged Roche 
X-ray films Roche 
Hybridisation Bags Roche 
Super Frost Slides Menzel-Gläser 
Cover Slips Menzel-Gläser 
Jung Tissue Freezing Medium Leica 
Kaiser’s Glycerine Gelatine Merck 
2.13.4 Kits 
ABI PRISM BigDye Terminators Cycle Sequencing 
Ready Reaction Kit Applied Biosystems 
Qiaprep Spin Mini- and Midiprep Kits Quiagen 
Qiaquick PCR Purification Kit Qiagen 
Qiaquick Gel Extraction Kit Qiagen 
RNeasy Mini Kit Qiagen 
PCR-Select cDNA Subtraction Kit Clontech 
SMART PCR cDNA Synthesis Kit Clontech 
DIG Luminescent Detection Kit Roche 
TOPO TA Cloning Kit Invitrogen 
PCR-Script Cam Cloning Kit Stratagene 
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2.13.5 Oligonucleotide primers [for sequencing or amplification of DNA-
 fragments by Polymerase chain reaction (PCR)] 
All primers were designed using the computer program Gene Runner, Version 3.0 
(Hastings Software Inc.) and purchased from MWG-Biotech. Degenerate primers specific 
for different classes of transcription factors were designed based on the conserved regions 
in the DNA-binding domain of transcription factor families. They are specified in detail in 
the results-section 3.1.1. 
Other oligonucleotide primers (nucleotide sequence is shown in 5’→3’ direction): 
T7-backward primer: TAATACGACTCACTATAGGG 
sp6-forward primer: TATTTAGGTGACACTATAG 
sp6-forward primer/TOPO: TATTTAGGTGACACTATAGTCGGATCCACTAGTAACG 
rat-CRHSP-forward: GCCATGTCATCTGAACCTC 
rat-CRHSP-backward: TCCTTAGGAGCTGATGACG 
anchor-primer 3’-RACE: GACCACGCGTATCGATGTCGAC 
race-zinc1A: GGGCTACACTCTGAACTCGAATCT 
race-zinc1B (nested): TCCAGGTCCATTTGCGAGTCCAC 
T7-zfp-mouse-forward: 
AAATTTTAATACGACTCACTATAGGGAGGACGCTGTACCAAGATG 
sp6-zfp-mouse-backward: 
ATTTTAATTTAGGTGACACTATAGAACTTGGTGAGGATCCGAGCTGG 
rat-zfp-1/backward: ACGGGTTCCCCAGTGCTTTTAC 
mouse-zfp-forward: CGAGGGAGAGAGATTCAGGGATTAAC 
mouse-zfp-backward1: GCCCTCCCTCCTGAGTCTAACACTTG 
mouse-zfp-backward2: TCGGTAACGGCTTCTCTG 
2.14 Animals 
Sprague Dawley rats, strain OFA Charles River Laboratories Inc. 
2.15 Frequently used buffers and solutions 
Solutions used for work with RNA were prepared in ddH2O, treated with DEPC (0,1%) 
and autoclaved or, alternatively, were directly prepared in DEPC-treated and autoclaved 
ddH2O. 
1x TAE (Tris acetate-EDTA) 40 mM Tris-Acetate 
 1 mM EDTA 
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TE-buffer 10 mM Tris-HCl, pH 8.0 
 5 mM EDTA 
1x PBS, pH 7.4 140 mM NaCl 
 2,7 mM KCl 
 10 mM Na2HPO4 
 1,8 mM KH2PO4 
6x DNA sample buffer 0,25% (w/v) Bromophenolblue 
 0,25% (w/v) Xylene Cyanol 
 30% glycerol 
2x RNA sample buffer 250 µl deionised formamide 
 100 µl 37% formaldeyde 
 100 µl 5x MOPS 
 1 µl Ethidium bromide (10 mg/ml) 
6x RNA loading buffer 0,5% SDS 
 25% glycerol 
 25 mM EDTA 
 250 µg/ml bromophenolblue solution 
RNA agarose gel (1,5%, 150 ml) 2,25g Agarose 
 25 ml 5x MOPS 
 100 ml ddH2O 
 boil in a microwave, then cool to 60°C 
 add 25,5 ml 37% formaldehyde 
5x MOPS 0,2 M MOPS 
 50 mM Sodium-Acetate, pH 7.0 
 10 mM EDTA 
 adjust to pH 7.0 with NaOH 
 store light protected at 4°C 
Maleic acid Buffer 0,1 M Maleic Acid, pH 7.5 
 0,15 M NaCl 
20x SSC 175,3 g NaCl 
 88,2 g Na-Citrate (trisodium-citrate dihydrate) 
 dissolve in 800 ml H2O 
 adjust pH to 7.0 with NaOH 
 fill up to 1l 
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Fixative 4% Paraformaldehyde in 1x PBS 
 add few drops of 1N NaOH 
 heat to 65°C for dissolving 
 filter 
Acetylation solution 0,1 M triethanolamine 
 add 0,25% acetic anhydride just before use 
Prehybridisation buffer (in situ-Hybridis.) 50% formamide 
 5x SSC 
 5x Denhard’s Solution (Sigma) 
 100 µg/ml sheared herring sperm (Roche) 
 250 µg/ml baker’s yeast tRNA (Sigma) 
Prehybridisation buffer (Northern Blot) 50% formamide 
 5x SSC 
 2% blocking solution (Roche) 
 0,02% SDS 
 0,1% N-Lauroylsarcosine 
DIG-Detection buffer 100mM Tris/HCl, pH 9.5 
 100 mM NaCl 
DIG-Colour reaction solution 10 ml DIG-Detection buffer 
 45µl NBT (75 mg/ml in 70% DMF) 
 35 µl BCIP (50 mg/ml in 100% DMF) 
 100-µl levamisol (24 mg/ml Detection buffer) 
Washing buffer 1 2x SSC 
 0,1% SDS 
 0,5% Blocking Reagent 
Washing buffer 2 0,1% SSC 
 0,1% SDS 
Washing buffer 3 0,1M Maleic Acid, pH 7.5 
 0,15M NaCl 
 0,3% Tween 20 
Washing buffer 4 (after stripping) 0,1 M Maleic Acid, pH 7.5 
 0,15 M NaCl 
 3% Tween 20 
LB-broth 1% Tryptone 
 0,5% Yeast Extract 
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 1% NaCl 
 adjust pH to 7.0 with NaOH and autoclave 
 add antibiotic after cooling to 55°C 
 (100 µg/ml Ampicillin or 
 10-20 µg/ml Chloramphenicol) 
LB-agar 1% Tryptone 
 0,5% Yeast Extract 
 1% NaCl 
 adjust pH to 7.0 with NaOH  
 1,5% Bacto-Agar 
 autoclave, add antibiotic after cooling to 55°C 
SOC-broth (for bacterial transformation) 2% Tryptone 
 0,5% Yeast Extract 
 10 mM NaCl 
 adjust pH to 7.5, autoclave and add: 
 2,5 mM KCl 
 10 mM MgCl2 
 10 mM MgSO4 
 20 mM sterile glucose 
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3 Results 
3.1 Identification of transcription factors in developing rat 
 cerebellum and entorhinal cortex 
The present approach aimed at the identification of transcription factors in rat cerebellum 
and entorhinal cortex, respectively, at the developmental age when extensive axonal 
outgrowth occurs in these brain regions. It was based on the method of “degenerate PCR” 
that employs degenerate primers for PCR amplification, which are specific for a conserved 
DNA region common to members of a certain class of molecules.  
3.1.1 Classes of transcription factors and generation of degenerate 
 primers 
Transcription factors are proteins that specifically bind to DNA and initiate transcription of 
certain genes. In principle, they consist of two different domains, a DNA-binding domain 
and a transactivation domain. The latter interacts with other proteins of the transcription 
complex and thereby assembles them at the promotor site of a certain gene to start its 
transcription. Both domains are separated by a variable spacer region. Some transcription 
factors additionally contain a dimerization domain, which is necessary for the formation of 
transcription factor homo- or heterodimers. Depending on the structure and sequence of the 
DNA-binding domain, several classes of transcription factors can be distinguished. Within 
one class, the DNA-binding domains are highly conserved on the amino acid level. (fig. 3-
1). In order to isolate transcription factors by PCR amplification, degenerate primers were 
generated on the basis of conserved DNA-binding domains of respective transcription 
factor classes (fig. 3-1). cDNA from either cerebellum at embryonic day 18 (CE-E18) or 
entorhinal cortex from neonatal rats (EC-P0) was taken as template for PCR amplification 
with degenerate primers. cDNA-synthesis was carried out by reverse transcription from 1 
µg total RNA extracted from CE-E18 and EC-P0, respectively. 
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POU:    L      E     Q     F     A      K     Q     F      K    Q/H 
degen. primer: CTG  GAR  CAR  TTY  GCY  AAR  CAR  TTC  AAG   CA 
 
   V      W      F     C      N     R      R      Q     K 
degen. primer: GTN  TGG  TKT  TGT  AAC  AGR  AGR  CAA  AAA 
 
HOX:   E      L      E     K      E    F/L   K      I      W      F     Q     N     R     R 
degen. primer: GAR  CTN  GAR  AAR  GAR  TT AAR  ATH  TGG  TTY  CAR  AAY  CGN  CG 
 
Zinc finger:   C      X      X     C      G     K   H     T      G      E     R/K     P      Y 
degen. primer: TGY  CCN  GAR  TGY  GGN  AA  CAY  ACD  GGH  GAR    CGY    CCN  TAY 
  
bHlH:    R      E     R     X     R   Y      I     D/E   A/V    L 
degen. primer: MGR  GAR  CGS  MRS  MG TAY  ATC    GAS     GYY    CT 
 
ETS:   W     Q     F     F/L    F/L   D/R N/K     M     N     Y     D/E    K 
degen. primer: TGG  CAR  TTY   YTN     YTN     SA  AAN    ATG  AAY  TAY    SAN    AAG 
 
Forkhead:   Y      I       A      L      I      T/A     M     A      I 
degen. primer: TAY  ATH  GCN  CTN  ATY    RCN    ATG  GCN  AT 
 
   N      S       I      R      H     N/S     L     S 
degen. primer: AAY  AGY  ATH  CGN  CAY    ARY    CTN  TC 
fig. 3-1: Conserved domains of selected transcription factor classes and primer design for PCR-
amplification of these regions with degenerate primers. 
In bold on the left side are given the different transcription factor classes. Amino acids of 
conserved DNA-binding domains are highlighted in red behind each transcription factor class. 
„N“ stands for any amino acid. The consensus amino acid sequence was taken as a basis to 
generate degenerate primers in order to amplify the class-specific domains by PCR. Primer 
sequences are shown as nucleotide triplets in 5’→3’ direction under the corresponding amino 
acid domain. Degenerate forward primers are underlined by a continuous line, degenerate 
backward primers by a dotted line. The following abbreviations were used for the selection of 
multiple nucleotides: R=A/G; Y=C/T; S=G/C; W=A/T; M=A/C; K=G/T; B=C/G/T; D=A/G/T; 
H=A/C/T; V=A/C/G; N=A/C/G/T. 
3.1.2 PCR-amplification of the conserved POU-domain 
The POU family is a group of related transcription factors with a particular type of 
bipartite DNA-binding domain, containing the POU-specific domain and the POU-
homeodomain (fig. 3-2). In order to amplify the DNA-binding domain by PCR from 
different transcription factors of the POU family, a forward primer was generated from the 
POU-specific domain and a backward primer from the POU-homeodomain.  
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fig. 3-2: schematic drawing of the conserved DNA-binding domain in POU-class transcription 
factors. 
The bar represents the amino acids of any given POU-transcription factor. The POU DNA-
binding domain comprises a POU-specific domain (highlighted by stripes) and a POU-
homeodomain (highlighted by little squares), which is located further to the c-terminus. For 
PCR-amplification of POU-transcription factors, a degenerate forward primer was chosen from 
the POU-specific domain and a degenerate backward primer from the POU-homeodomain. As 
both domains as well as the spacer region in between are fairly constant in length, the 
amplified PCR product is predicted to consist of approx. 420 bp. 
All PCR amplifications using degenerate POU-primers were performed as follows: 
 initial denaturation step: 94°C – 2 min. 
 denaturation: 94°C – 30 sec. 
 primer-annealing: 45°C – 45 sec. 33x 
 elongation: 72°C – 1min. 
 final elongation step: 72°C – 7 min. 
To confirm the specific amplification of the POU-domain with the degenerate POU-
primers, a plasmid, in which the POU domain gene Tst-1 was inserted (pBKSII-/Tst-1), 
was used as a control template in the PCR approach. A distinct DNA-fragment of approx. 
420 bp was amplified in the control (fig. 3-3, lane 1), indicating that the PCR conditions 
were set up correctly. Likewise, a distinct PCR product of 420 bp was detectable in the 
reaction using cDNA from embryonic cerebellum as template (fig. 3-3, lane 2). In a 
subsequent PCR, this product was specifically re-amplified using an aliquot of the first 
reaction as template and the same primers for amplification (fig. 3-3, lane 3). This 
confirmed the specificity of the POU-fragment amplified in the first experimental reaction. 
The size of the PCR-product (420 bp) corresponded with the predicted size of the DNA-
fragment. A certain variability in size occurs due to the variable linker region between the 
POU DNA-binding domain and homeodomain. 
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fig. 3-3: PCR amplification of the conserved POU DNA-binding domain in rat embryonic 
cerebellum using degenerate POU-primers. 
To amplify a 420 bp fragment of the conserved POU DNA-binding domain, the following 
templates were employed: lane 1: 200 ng control plasmid pBKSII-/Tst-1, in which the POU-
transcription factor Tst-1 is inserted, lane 2: 5 µl cDNA, which was reverse transcribed from 1 
µg total RNA from rat E18-cerebellum (first amplification), lane 3: 0,5 µl of the first 
amplification product shown in lane 2 (re-amplification). 
In the entorhinal cortex of newborn rats, a 420 bp POU-fragment was similarly amplified 
by PCR with degenerative primers (data not shown). 
The 420 bp band was extracted from the agarose gel, purified and cloned into the pCR-
Script CAM cloning vector (Stratagene). This plasmid carries a chloramphenicol resistance 
gene, which allows transformed bacteria to grow in the presence of the antibiotic 
choramphenicol. XL1-Blue bacteria were transformed with this construct, selected for 
chloramphenicol resistance and the amplified plasmid DNA of growing colonies was 
subsequently isolated by mini-prep (Qiagen) and sequenced. Sequence analysis of 35 
inserted cDNA fragments was performed with the computer programs Chromas and 
BlastN by the blastn and tblastn sequence alignment algorithms (Altschul et al., 1990). In 
26 cases a homology to two known rat POU class III transcription factors, brain-2 and 
brain-4, was observed. The residual 9 clones did not contain any insert or produced 
defective sequence results. Whereas the brain-4 cDNA fragment was amplified by 
degenerate POU primers in cerebellum as well as in entorhinal cortex, the brain-2 cDNA 
fragment was isolated only from entorhinal cortex. As function and expression patterns of 
both proteins are well examined (He et al., 1989; Le Moine and Young, 1992; Mathis et 
al., 1992; reviewed by Rosenfeld, 1991) and no further cDNA-fragments from different 
POU- transcription factors were amplified, the following PCR approaches with degenerate 
primers concentrated on other transcription factor classes. 
Results 
 
39
3.1.3 PCR-amplification of the conserved C2H2-Zinc finger domain 
In most zinc finger transcription factors, the conserved zinc finger domain (fig. 3-4) does 
not exist in a single form but is arranged in repeats with short spacer regions in between. 
As a consequence, degenerate zinc finger primers can bind to more than only one site in 
the conserved region. This results in amplification of multiple PCR products as illustrated 
in fig. 3-4. 
 
fig. 3-4: Schematic illustration of the conserved C2H2-zinc finger domain. 
The line represents the amino acid sequence of any given C2H2-zinc finger transcription factor. 
Bulges indicate the tertiary structure of the protein, which occurs by complexing a zinc ion by 
two conserved cysteine (C) and two histidine (H) residues. As this domain is often arranged in 
a repeated pattern degenerate zinc finger primers are able to bind the DNA of such a protein at 
multiple sites. They therefore can generate several amplification products, a ladder of bands, 
depending on the number of domains present in the zinc finger protein. The smallest amplified 
unit corresponds to a single domain, which is approx. 80 bp in length. Each additional domain 
will result in the amplification of a PCR product, which is approx. 85 bp longer. 
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Cycling parameters for PCR-amplification of C2H2 –zinc finger domain transcription 
factors with degenerate zinc finger primers were as follows: 
 initial denaturation step: 94°C – 2 min. 
 denaturation: 94°C – 30 sec. 
 primer-annealing: 42°C – 45 sec. 30x 
 elongation: 72°C – 1 min. 
 final elongation step: 72°C – 7 min. 
Fig. 3-5 shows the amplification of zinc finger regions in rat cerebellum (CE-E18, lane 1) 
and entorhinal cortex (EC-P10, lane 2). The degenerate zinc finger-PCR resulted in 
multiple amplification products of one or more fingers in form of a ladder. In cerebellum 
and entorhinal cortex, the largest amplified fragment was 510 bp in length, correlating to 
six zinc finger domains. 
Fig. 3-5: PCR amplification of C2H2-zinc finger domains in rat cerebellum at E18 and in 
entorhinal cortex of neonatal rats. 
1 µg of total RNA from either E18-cerebellum or P0-entorhinal cortex were reverse transcribed 
and used in a PCR with degenerate zinc finger primers. Multiple PCR products were amplified, 
corresponding to the number of zinc finger domains present in a single zinc finger protein. The 
PCR fragments correspond to the calculated sizes of consecutively positioned zinc finger 
domains (see fig.3-4). 
PCR-amplified zinc finger cDNAs that contained at least 3 conserved zinc finger domains 
were excised and eluted from the agarose gel and cloned into the pCR-Script CAM 
Cloning Vector from Stratagene. Constructs were transformed into XL1-Blue bacteria, 
which were then selected for choramphenicol resistance. 24 bacterial clones were selected 
for amplification and plasmid preparation. The cloned PCR-fragments were sequenced and 
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analysed with the computer programs Chromas and BlastN. 19 of all sequenced cDNAs 
showed homologies to zinc finger proteins from other species. Remaining clones contained 
unknown cDNAs. However, as the amplified PCR products consisted almost exclusively 
of conserved zinc finger domains, they could not be used as tools for the further 
characterization of these genes. In particular, a certain amount of gene-specific sequence 
information outside the conserved region was necessary for a good comparison of the 
cloned gene fragments with zinc finger proteins from other species and to generate gene-
specific probes for subsequent expression analyses. Therefore, the RACE-method was 
applied which allows a selective elongation of either the 3’-or the 5’-end of any given 
sequence of an unknown gene. A cDNA sequence, which contained 3 zinc finger domains 
and showed homology to a mouse zinc finger protein was chosen for RACE-elongation. In 
the following, the gene and protein for this cDNA were named zfp-1. Two forward-primers 
were generated for this clone, both binding specifically between two conserved zinc finger 
domains (‘primer 1’ and a further 3’-binding primer ‘nested primer 2’). An approx. 330 bp 
fragment was amplified in a first 3’-RACE-PCR using ‘primer 1’ and was re-amplified in a 
second RACE-reaction with ‘nested primer 2’ (Fig. 3-6). After elution from the agarose 
gel, the fragment of interest was cloned and the DNA sequenced. Sequence analysis 
resulted in the identification of the 3’-cds of zfp-1. 
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Fig.3-6: 3’-RACE (Rapid Amplification of cDNA ends) with the 3 zinc finger-domain containing 
cDNA zfp-1. 
A PCR-amplified cDNA from CE-E18, containing 3 zinc finger domains and named zfp-1, was 
elongated at its 3’-end by 3’-RACE-PCR. A first RACE-PCR resulted in an approx. 330 bp 
cDNA fragment (lane 2), which was clearly re-amplified in a nested RACE-PCR (lane 3). A 
DNA size marker was loaded on lane 1. 
Both sequences for zfp-1, the first obtained by degenerate zinc finger-PCR and the second 
obtained by 3’-RACE, were assembled at their overlapping regions with the help of the 
computer program Gene Runner. This resulted in a total sequence length of 527 bp of the 
identified rat zfp-1 clone, containing 5 conserved zinc finger regions and the 3’-end of the 
coding region. Using this sequence, a new search in the GenBank database was 
accomplished in order to find homologous sequences from other species and overlapping 
rat EST-clones. A zinc finger protein from the mouse, Zfp61 (accession numbers: L28167 
and NM_009561) displayed strong homology to the identified zinc finger protein zfp-1 in 
the rat (88% identity of nucleotides). The next step aimed at confirming the homology 
between rat zfp-1 and the mouse zinc finger protein outside the conserved zinc finger 
region. A forward and backward primer were therefore generated from the non-conserved 
5’-cds of the mouse zinc finger protein Zfp61. Based on the strong homology found in the 
conserved 3’-cds between mouse and rat, these primers were used in a PCR with rat brain 
tissues from different developmental stages (Fig. 3-7). PCR yielded an approx. 600 bp-
product - corresponding to the calculated size from the mouse sequence - which delivered 
new sequence information about the 5’-cds of rat zfp-1. Comparison of the 600 bp-
sequence with the homologous sequence span in mouse resulted in 80% identity on the 
nucleic acid level. Conservation of the nucleic acid sequence was thus similar in the 
conserved and in the non-conserved region between both species. 
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Fig. 3-7: PCR-amplification of the 5’-region of the coding sequence (cds) of rat zfp-1. 
The forward primer was generated from the 5’-region of the mouse homologue of rat zfp-1. It 
was used in a PCR reaction together with a backward primer, generated from the RACE-
elongated 3’-end of rat zfp-1. cDNA from rat cerebellum or entorhinal cortex at different 
developmental stages was taken as template for PCR. The PCR product, which was approx. 
600 bp in size, was amplified in cerebellum and entorhinal cortex at different developmental 
stages. 
In order to generate DIG-labelled probes for expression studies by non-radioactive in situ-
hybridisation, two primers were designed which were specific to the non-conserved region 
of rat zfp-1 and to which promotor sites for T7- and sp6- RNA-polymerases were attached. 
This allowed synthesizing DIG-labelled riboprobes directly from the PCR product. The 
riboprobes were used for analysis by in situ-hybridisation on rat sagittal brain sections. 
Several different concentrations of antisense and sense riboprobe were used. Although 
many parameters of the protocol for in situ-hybridisation were varied, the sense probe 
always yielded in hybridisation patterns similar to the antisense probe. It therefore was 
impossible to analyse the expression pattern of zfp-1 in rat brain during early postnatal 
development. Because of the extreme time-consuming approaches required for generation 
of zinc finger gene-specific sequences outside the conserved domain it was decided to not 
further study up the identified zinc finger containing cDNAs. 
3.1.4 PCR-amplification of the conserved HOX-, ETS-, Forkhead- and 
 bHLH-domain 
Using degenerate primers for the HOX-, ETS-, Forkhead- and bHLH- transcription factor 
classes in PCR approaches, no specific PCR products were amplified. Plasmids that 
contained the cDNA for a specific transcription factor of each class were used as control 
templates in the PCR. With none of these it was possible to amplify the conserved domain 
using the adequate degenerate primers. PCR always produced multiple bands, none of 
which corresponded to the size of the conserved transcription factor domain. Most 
probably, the degeneration of the primers was too high resulting in unspecific primer 
binding and amplification of unspecific cDNA fragments. 
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3.1.5 Short Résumé 
The original project of identifying transcription factors associated with axonal growth 
based on PCR amplification with degenerate primers resulted in the cloning of several 
cDNAs representing transcription factors from the POU and zinc-finger families. For the 
other transcription factor families it was not possible to design primers with a sufficient 
degree of degeneration to allow the identification of novel family members because the 
degenerate primers did not result in the amplification of any PCR products. With the POU-
specific primers only two POU genes were identified which were already extensively 
studied and were unlikely to play a major role for axonal outgrowth. The most promising 
results were obtained with the zinc finger specific primers, which yielded a number of 
cDNAs coding for zinc finger domains, not represented in the database. Due to the 
structure of the zinc finger proteins and the location of the primers it was not possible to 
amplify cDNAs outside the zinc finger domains. Due to the high conservation of these 
domains it was not possible to use these probes for further analysis of the genes, e.g. by 
Northern blotting or in situ-hybridisation. For the generation of a meaningful cDNA probe 
it was necessary to extend the cDNA by the RACE procedure. Unfortunately, it was very 
time-consuming to generate cDNAs by 3’-RACE specific for originally amplified zinc 
finger cDNAs. In the one example where the procedure worked successfully the generated 
probe still was not appropriate for in situ hybridisation experiments. For these reasons it 
did not appear to be promising to further pursue this approach. Another strategy was 
therefore started which was methodically different but followed a similar goal. In order to 
identify genes that are highly expressed in late embryonic or neonatal brain in regions 
where massive fiber outgrowth occurs at that time but which are downregulated after 
cessation of axonal outgrowth, a subtractive hybridisation approach was performed with 
two rat brain tissues, embryonic cerebellum and neonatal entorhinal cortex. Compared to 
the first approach, the aim of the new strategy was to increase the number of molecules to 
be further analysed and to reduce the number of molecules that are equally expressed 
during development of the CNS and in the adult brain. Thus, the selectivity for 
transcription factors was given up, and the scope was widened to all classes of molecules 
that are developmentally regulated during the postnatal decrease of axonal growth 
competence. 
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3.2 Identification of genes developmentally regulated in 
 postnatal rat brain during neuronal differentiation 
3.2.1 Suppression Subtractive Hybridisation with rat cerebellum at two 
 developmental stages 
The age-dependent decrease in axon growth potential is well studied in the rat cerebellum 
in vitro and occurs in the early postnatal period around postnatal day 7 (P7) in cerebellar 
Purkinje cells (Dusart et al., 1997). This study served as a basis to determine the time 
points for the cerebellar subtraction approach: embryonic day 18 (E18), corresponding to 
the time point of beginning differentiation of cerebellar Purkinje cells, and postnatal day 35 
(P35), when axonal projections of all cerebellar neurons are established. By subtraction of 
CE-P35 from CE-E18 transcripts, genes that are stronger expressed at E18 and which are 
downregulated at P35 were enriched. Fig. 3-8 demonstrates the differential PCR 
amplification patterns of transcripts from rat cerebellum at E18 before and after 
subtraction. As expected, clear differences in the banding patterns were visible: some 
amplification products that were present before subtraction had disappeared or were more 
faint after subtraction, others were distinct after subtraction but could not be discerned 
beforehand.  
The PCR amplified cDNAs were cloned and the yield of the generated subtractive library 
was roughly estimated by evaluating the total number of white bacterial colonies grown 
under antibiotic selection and considering the number of clones containing defective 
inserts or being present in multiple copies. About 800 independent clones were calculated 
for the cerebellar subtraction approach. Of those, 65 clones were randomly chosen for 
sequence analysis. By comparison with the databases, 30 clones were found to be identical 
to known rat genes or highly similar to homologues in other species. 7 sequenced cDNA 
fragments were completely unknown and 4 clones corresponded to rat EST sequences. Six 
sequences were found twice. Remaining clones (18) did not contain a specific insert or 
produced defective sequence results. 
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Fig. 3-8: Enrichment of transcripts present in rat cerebellum at E18 by suppression subtractive 
hybridisation  
Comparison of gene expression profiles from rat cerebellum at E18 and P35. Transcripts more 
abundant at E18 than at P35 were enriched during the subtraction approach, whereas transcripts 
equally present in both populations were suppressed. In a final PCR step, enriched transcripts 
were amplified (left lane). As a control, PCR-amplification of all transcripts from E18-
cerebellum before subtraction is shown (right lane). Pronounced differences between both 
lanes are visible: as an example, some enriched cDNAs (distinct after subtraction in the left 
lane) are marked by an arrow, suppressed cDNAs (more abundant before subtraction in the 
right lane) are marked by an asterisk. 
Proteins encoded by known genes were classified into 6 groups: (1) transcription factors 
and other nuclear proteins, (2) cytoskeletal proteins, (3) signalling molecules, (4) enzymes, 
metabolic proteins and transporters, (5) cell surface molecules and (6) growth associated 
proteins. This classification is shown in table 3-1. For some of the subtracted genes data 
are present in the literature showing that they are downregulated in particular brain regions 
during development on either transcript or protein level. These genes are indicated by an 
asterisk (*) in table 3-1. This confirms that the used subtraction method indeed enriched 
for differentially regulated genes that are expressed more abundantly in developing than in 
mature CNS. The generated subtractive cerebellar cDNA library thus provides a reliable 
tool to search for possible candidate molecules that might play a role in neuronal 
differentiation. 
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Classification groups Protein products of identified genes 
 
 
transcription factors and other nuclear proteins human TAR-DNA-binding protein TDP-43 
 human zinc finger protein BCL11A 
 rat cyclin D2 
 human / mouse DYRK-kinase 2 
 rat U5-snRNP 
 mammalian basal Histone protein H2A.Z 
 hnRNP R 
 rat helix destabilizing protein hnRNP A1 
 human nuclear import receptor snurportin-1 
  
cytoskeletal proteins rat nestin * 
 rat class I β-tubulin * 
 rat cytoplasmic form of χ-actin 
 rat α-tubulin 
  
signalling molecules rat ras-GTPase activating protein ras-GAP 
 mouse quaking gene product QKI-7 
 rat calcium-regulated heat stable protein CRHSP-24 
   
enzymes, metabolic proteins and transporters human GPI transamidase 
 rat ubiquitin carboxyl-terminal hydrolase PGP 9.5 
 rat heme-oxygenase 2 
 mouse WRS tryptophan tRNA-ligase 
 human peroxisomal integral membrane protein PMP34 
 rat differentiation-assoc. phosphate cotransporter DNPI 
 rat cytochrome c 
  
cell surface molecules rat neuronal surface glycoprotein MRC OX-2 * 
 rat neurotrimin * 
 rat CD24 * 
 rat HB-GAM / pleiotrophin * 
  
growth associated proteins rat thymosin-β4 * 
 rat SCG-10 * 
 rat cytosolic phosphoprotein p19 / stathmin * 
  
Table 3-1: Classification of protein products of genes enriched in a subtractive library of rat 
cerebellum at E18. 
Specified in this list are those clones identified in the subtraction which are identical to known 
rat genes or which displayed a strong similarity to homologous genes in mouse or human (30 
of 65 sequenced clones). Proteins for which data in the literature show that they are 
downregulated during brain development either on transcript or protein level are indicated by 
an asterisk (*). 
3.2.1.1 Identification of downregulated CRHSP-24 gene expression during 
brain development 
One of the clones (clone 11) identified in the cerebellar subtraction approach was about 
560 bp long and showed striking homology to the 3´-untranslated region (UTR) of mouse 
calcium-regulated heat stable protein CRHSP-24 gene (accession number: AK004711). In 
the database, the corresponding homologue in rat was found. This sequence (accession 
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number AF115346) consists of the complete coding sequence (cds) for rat CRHSP-24 but 
lacks the 3´-UTR. These findings led to the conclusion that the identified clone of the 
cerebellar subtractive library corresponds to a part of the 3´-UTR of the rat CRHSP-24 
mRNA. This clone seemed interesting for further expression analysis as the corresponding 
protein functions as nucleic acid binding protein (see Discussion, section 4.4) and the CNS 
expression of CRHSP-24 had not yet been examined, neither in the rat nor in other species. 
To confirm the differential expression of this gene during development, Northern 
hybridisation of total RNA from multiple rat brain tissues at different developmental stages 
was performed with the isolated CRHSP-24-fragment as cRNA probe (fig. 3-9). 
In summary, the results showed the presence of two rCRHSP-24 transcripts in all brain 
regions tested, a larger transcript at about 2,9 kb and a smaller one at 1,7 kb. The larger 
transcript was strongly expressed at late embryonic stages in all four brain regions 
analysed and showed a clear downregulation in cerebral cortex, hippocampus and 
cerebellum with only weak expression in the adult. In cerebral cortex as well as in 
hippocampus, the peak expression was before birth (E18 was the earliest stage examined) 
and then declined until P10. Moderate transcript levels were still expressed in cerebral 
cortex at P10, whereas hippocampal expression at P10 had already reached the low levels 
seen in the adult. In cerebellum, downregulation occurred more slowly: expression was 
maximal at P0, declined to moderate levels at P10 which stayed until P35, and then further 
decreased in the adult. In brainstem, transcript expression was strong at E18, increased 
until P10 and was downregulated at P35.  
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Fig. 3-9: Northern analysis of rat CRHSP-24 mRNA in multiple brain tissues during development. 
The membrane containing 5 µg total RNA of multiple brain tissues from different 
developmental stages (embryonic day 18, postnatal day 0, 10, 35 and adult) was hybridised 
with 300 ng/ml of DIG-labelled rCRHSP-24 cRNA probe (top panels, a). Exposure time of the 
X-ray film was 1h. Rat brain tissues from which RNA was isolated and their developmental 
stages are indicated at the top of each figure. No preparations of total RNA from P35-cortex 
and adult brainstem were available. As a control for equal loading of total RNA on each lane, a 
UV-photograph of the 28S-rRNA on the membrane after overnight blotting is shown (bottom 
panels, b). The larger of the two rCRHSP-24 transcripts (2,9 kb, upper panels) was strongly 
downregulated in cerebral cortex and hippocampus early in postnatal development. In 
cerebellum, downregulation occurred more slowly: expression was maximal at P0, declined to 
moderate levels at P10 which stayed until P35, and then further decreased in the adult. In 
brainstem, peak expression occurred at P10 and was downregulated at P35. In the adult, weak 
transcript levels were still present in all brain regions tested. 
In situ-hybridisation was performed with the rCRHSP-24 cRNA probe on rat sagittal brain 
sections of different developmental stages to examine the distinct expression pattern of 
rCRHSP-24 during neuronal differentiation in the CNS. Unfortunately, it was not possible 
to obtain satisfactory in situ-hybridisation data for this clone although many different 
protocols were tried. Even with a rCRHSP-24-riboprobe which was newly generated based 
on the published cds of the rCRHSP-24 gene and which was non-overlapping with the 
originally used probe, the efforts to obtain specific hybridisation signals remained without 
success. 
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3.2.1.2 Isolation and characterization of the rat gene for ubiquitin-
conjugating enzyme E2 variant MMS2 
A different subtracted clone (clone 14) displayed a significant alignment with the mouse 
gene for ubiquitin-conjugating enzyme-like protein MMS2 (accession number AK019486; 
350 identities of 358, 97% identity, Score: 646 bits and e-value: 0 with BlastN;), which is a 
highly conserved protein even in non-vertebrates, e.g. yeast. In yeast it was first isolated 
and discovered as a protein which is highly similar to a family of ubiquitin-conjugating 
enzymes (E2-enzymes), but which lacks the essential cysteine residue at the active site and 
therefore is not functional in ubiquitin-conjugation. The isolated 373 bp cDNA fragment of 
clone 14 (deposited in DDBJ/EMBL/GenBank databases under accession number AJ 
515244) was highly similar to the 5’-end of the cds for mouse MMS2, the total length of 
which is 438 bp. Searching for overlapping rat ESTs delivered a sequence with the 
accession number BG 664464 (Score: 673 bits, e-value: 0) which contained the complete 
cds for the rat homologue of mouse ubc-like protein MMS2. The open reading frame (orf) 
consisted of 145 aa and the predicted molecular weight for rat MMS2 protein was 16 kDa. 
Another rat EST-sequence (accession number BI 295928) was found to overlap with BG 
664464 (97% identity) at the 3’-end. A search in the rat HTGS-database yielded a genomic 
sequence (accession number AC114032) that correctly overlapped with the originally 
isolated clone and also with both EST sequences described above. The overlapping 
sequences were interrupted by two sequence stretches, indicating that the rat MMS2 gene 
contained at least two introns. AC114032 further supplied the 3´-UTR of the gene, which 
was highly similar to the mouse homologue (AK019486). By compilation of the initially 
isolated clone from the cerebellar subtractive cDNA library and the sequence fragments 
from AC114032, a 3248 bp sequence was obtained which is shown in fig. 3-10. This 
sequence displayed 91% identity to the mouse homologue in the coding region and 
between 80 % and 91% identity in the 3´-UTR. The deduced amino acid sequence shared 
99% identity with mouse MMS2 as well as with the human homologue (human ubiquitin-
conjugating enzyme E2 variant 2, Ube2v2, or human MMS2) and was 50% identical to 
yeast MMS2. Northern hybridisation results indicated that this 3248 bp DNA represented 
the full length transcript, as an approx. 3 kb-transcript was detected in addition to a major 
1,7 kb-transcript (see also section 3.2.1.3). This is further supported by the sequence length 
of the mouse cDNA for MMS2 (3272 bp), which was isolated from a full-length enriched 
library and correlates well in size to the rat sequence described above. Based on the 
striking sequence similarity, the 3248 bp DNA fragment was thus designated as rat MMS2 
cDNA and deposited in the DDBJ/EMBL/GenBank databases (accession number: 
BN000090). 
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M  A  V   S  T  G  V   K  V  P  R  N  F   
1 ACGCGGGGGA GAAGGAGAAG ATGGCGGTGT CCACAGGAGT TAAAGTTCCT CGTAATTTTC 
R  L  L  E   E  L  E   E  G  Q   K  G  V  G   D  G  T  V  S  W   
61 GCTTGTTGGA AGAACTTGAA GAAGGACAAA AAGGAGTAGG TGATGGTACG GTTAGCTGGG 
G  L  E  D   D  E  D   M  T  L   T  R  W  T   G  M  I  I  G  P   
121 GCCTTGAAGA TGATGAAGAC ATGACACTTA CAAGGTGGAC AGGCATGATT ATTGGGCCAC 
P  R  T  N   Y  E  N   R  I  Y   S  L  K  V   E  C  G  S  K  Y   
181 CAAGGACAAA CTATGAAAAC AGAATATACA GCCTGAAAGT AGAATGCGGA TCTAAATACC 
P  E  A  P   P  S  V   R  F  V   T  K  I  N   M  N  G  I  N  N   
241 CAGAAGCACC TCCATCCGTT AGATTTGTAA CAAAGATTAA TATGAATGGG ATCAATAATT 
S  S  G  M   V  D  A   R  S  I   P  V  L  A   K  W  Q  N  S  Y   
301 CCAGTGGAAT GGTGGATGCA CGGAGCATAC CAGTATTAGC AAAATGGCAA AATTCCTATA 
S  I  K  V   V  L  Q   E  L  R   R  L  M  M   S  K  E  N  M  K   
361 GCATTAAAGT TGTACTTCAA GAGCTAAGAC GTCTTATGAT GTCCAAAGAA AACATGAAGC 
L  P  Q  P   P  E  G   Q  T  Y   N  N  
421 TTCCACAGCC ACCAGAAGGA CAGACATACA ACAACTAATT TTAGTGGATC TCAAACTTGT 
481 CTTAAATCAA CAACCTTCTA CTCATGTTAA TGTCTTGATT AAATATCACC ATGCAAAATA 
541 CCCACACATT AAGTAAAAGA ATTGCAGCTG GTAAACATGA CCTGGACAGT TGTAAGAATA 
601 TATTTAATAT ATGTACACCT ATTATGTTTT CAGGTAACAA GAGAAGTGCA GCACAATTTT 
661 TCTTTCTCTT CTTAAAAGCA CTGTCATTTA AACATGAATC TGAAGCATTC AAAATGGAAT 
721 TCAGGTTGTC AAGACAGAAG CATGGCAAAA GAGTGTCAGA TGGCCACGGG AACCTTTGTT 
781 TTTCTGAAAG TAAAGTCTCA AGAAAGAAGA ACAGAACTGG CAGGCTTTAT CCACCATATT 
841 TAGAGCTGCA GATGGAATTG TTTAAAGTAG CAGACATAAT GACTAGTCAC CAATTGTGTT 
901 AATCCTTGAA GCGGTGTGGG TGCTGACTAC TGTTAGTGTC AAACATAGGT GCAGGATGGT 
961 TTTGATACCT GTATTTATAA TAAAAAGATG TTTGGGGTTT TGAATTTCTG TTAAAAGCTG 
1021 TTCTCGTTTG TTACATGTAA CAGACATGAT AAGTTGTTTA CAGTCTTTGT TTAATAAAAC 
1081 ATGCTTAGAA GTTTTAAGTG AAGACAACAA AAAGGAAATA GGTGTTGGAT ATGTGATTTT 
1141 GAGATGAAAG TTAGTCTTAA AATGTAAATA AAATATGGAA TGTGTCTTCA AAGACTGTGC 
1201 TATTTCTGTT ACATTGATAT ATGCTATAGT AGCCATATCA AGGTAGCAAA ATTGGGGGTT 
1261 ATTAAGCTAG GCATGGTAAT GGCAAAAGCA GGAAGATTTT CAGTTCCAGG CCAGCTTGGG 
1321 CTGATACATA AGATTGTATG TAAAACCAAA GAAATAATGA GAGAATATCA AAGATTTTCA 
1381 TTGAAATTCT ATTTTATATG CTTATGTTTG GAACTTACAG AGCATCTTTT TGACTTCTTA 
1441 CATGCTCAGT TTAATTTCTT TGCACAAAGA GGTATCTCGG TTACTACATT TCAAGTTTTA 
1501 TTTCATCATG GGTAATTTTA AAATTGCATT TTAGCAATTT TCATAGTTAC AGACTGCAAA 
1561 TTATTCAAGT ACTCATTCAT TTTTTTCTTT ATGACTTATT TTTCTATGAA GCTTTTGGTT 
1621 CATTACAGTT GACTGAATTG AAGACATTTC TTCACCTGTC TTTACATTTT TTTTTTACTT 
1681 TATTTGTGTG TGTGTATGTG TGTTGTGTGT GTGCGCACAT GCACATATGT GTGTGTACAC 
1741 TTGTATGAAG GTCAAAGGTT ACCTTTGGAG TTGGTTCTTG CCTTCACTTT TATATGTGTT 
1801 CCTGATGTCA AACTCTGATC ACCATGTACC ATCTGTCTGA ATAAGGGAAT GAGTGCCTTC 
1861 ACTGAAGAGT CATCTCATTG GTCCCTCTTC TAAGACCAAT GAAAGTTAAT TTTATCATTC 
1921 CACTCCACAT TCACTTTAAC AAATATGTGT CTGAAGTTGA AAGTTCATTT TTATTCTTTT 
1981 ATCATATTGA CAAAGTTTGA TTGTCAAAAT AAAAAATTAG ATGTTCAAGC TTTGCCTATA 
2041 AAGAAAGTAA AGGAAAAGTA TTACTAGTAG ACTGGATTAT TTTGGTTACT TTTATAGCCA 
2101 AGACAGGTTT CTTTAAACAT ACTTGGCATG TTTTGATTAA GCTGTTTAAA AATTAACCTT 
2161 TTTTTAGTTA GCATTTCATT AATTAAACAC TAGACATTTT GTCTAAACAT TATCATCACT 
2221 TTTGTATTTT GAAACAGTAT CACCTATGAT AGCCTCAAAC TTGCAGAATT ACTTCTGTCT 
2281 CAACCTCTCA AGTACTGGTT CTGGTGTACA CTGCAATGTC CAGAATAGAT GGACTCATTT 
2341 TAAATGAACT AGTTAATTAT CAGCGAGGTT TCTTTATTCT TTGTGTGTGT GTGTGTGTGT 
2401 GTAGGTGGGG AGGAGTAGTG GTGTATACAG AAGCCTTAGG TTGACGTCTG GAGTCTCCTT 
2461 TAATTGCTCT TTCACTTTAT ATAGTGTGAG ACAGGGTTTC TAAATGAAGC TCACTGATGC 
2521 GGCTAGACTT GCTAATCAGC TTGCTACCAA GATAGATCCC CTGCCTCTGC TTTCCAAGGC 
2581 CGGAATTACA GCCTCAACTG TTATTTTATG TGGGTTCTAG GGATCTGATA TCCGACGAGC 
2641 ATTTTCGACC ATTGAGCCAT CTCAGTCCCT CAAAAATGTT CTAAGTATTT AAAAATCACA 
2701 CAGAATGTAC ACATTTTCCA TGCGTTAATT ATTAAAGTAG ACTTAAACAT TATACTTAAT 
2761 ATTTAATGGT TAAAGATTAC ATTGAATTGC GATACTATAG AATCATTATC AGTCTGTTTT 
2821 CTGCCTTGAA AATGTGTCTT GTGATACTTG GAAACTAGAA AGTATTGGGA TGCTTTTGAT 
2881 AGGCTCTGAT AGAATCTCGT ACTTTGGTCT CATGTTGTCT TTGTGTATGC TACCCAAGGC 
2941 TGTTGTCAGA CAGAGTCCTA CCTATTTAAA AAAAAGGGGG ATTGTTGATT TTAGCAGAAA 
3001 TCTACGAGTC AGTTAAAAGA TTTCCAAAGC AAAATCCATT TTGCATGTAG CAATTATATA 
3061 TGATAATCTA AGATATATTA ATTCATGAAA TTTTAGAGTC TTATAATTAT AAGACAGAAG 
3121 TTTAAAAGGA AATTTTCCTT TGTAAAGTGG CTAGGGTTGC AGGAATGTTG TGGTATAGAC 
3181 TAGAAAGTTG CCTTAGAAAT TTGTTTCAAG AGATTTTTAA GGATGACCCT TGATGCCTGT 
3241 ATGTTAAT 
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Fig. 3-10: The nucleotide sequence of rat MMS2 cDNA. 
The sequence was constructed from the subtracted cDNA clone 14 (the first 373 bp, deposited 
in the DDBJ/EMBL/GenBank databases under accession number AJ515244) and an 
overlapping rat genomic-sequence from the HTGS database (AC114032). Coding sequences 
were identified by homology to rat ESTs (BG664464 and BI295928). The numbers in the left 
column refer to the nucleotide positions. The predicted amino acid sequence of rat MMS2 
polypeptide (145 aa) is shown above the corresponding nucleotide sequence. The sequence of 
rat MMS2 cDNA has been deposited in the DDBJ/EMBL/GenBank databases (accession 
number: BN000090). A potential phosphorylation site for cAMP-dependent and Ca+/ 
calmodulin-dependent protein kinases is highlighted with a box. 
3.2.1.3 Northern analysis of rMMS2 transcript in brain from late embryonic 
development until adulthood 
In order to clarify whether rMMS2 might possibly be involved in the establishment of 
neuronal connectivity in the developing CNS, the first aim was to elucidate its expression 
pattern in brain during postnatal development. Therefore, the developmental regulation of 
rat MMS2 expression was studied by Northern hybridisation analysis on several brain 
regions at different developmental stages (fig. 3-11). The cRNA-probe for rMMS2, which 
was made from the originally identified cDNA fragment and is specific to a large part of 
the cds, hybridised with a major transcript at 1,7 kb in all brain regions tested. A minor 
transcript, between 2,7 and 3,7 kb in size, was also observed, but, at the probe 
concentrations used, the signal for this larger mRNA was very weak and was visible only 
in cerebral cortex and hippocampus at E18, independent of the exposure time (not shown). 
The 1,7 kb transcript is likely to be generated by alternative splicing as the gene for 
rMMS2 consists of several exons (see section 3.2.1.2) or, alternatively, might arise by 
usage of an alternative polyadenylation site. The results revealed a high expression of rat 
MMS2-mRNA in cerebral cortex, hippocampus and cerebellum at late embryonic 
development (E18) and a strong downregulation at birth in hippocampus and at P10 in 
cerebral cortex and cerebellum. The transcript was further downregulated at P35 in 
hippocampus and cerebellum and was absent in the adult. In brainstem, the signal was 
weaker and remained constant until P10 but was absent at P35. After overnight exposure of 
the X-ray film to the chemiluminescent signal, low transcript levels could also be detected 
in the hippocampus, but not in cerebral cortex, cerebellum and brainstem. 
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Fig. 3-11: Northern analysis of rat MMS2 mRNA in multiple brain tissues during development. 
The membrane containing 5 µg of total RNA (the same that was used for hybridisation with 
rCRHSP-cRNA probe in fig. 3-9) was stripped as described in Materials and Methods and 
subsequently hybridised with 300 ng/ml of DIG-labelled rMMS2-cRNA probe. Exposure time 
of the X-ray film was 15 min. (upper panels, a) or overnight (lower panels, b). A control for 
equal loading of total RNA on each lane was shown in fig. 3-9 (lower panels, b). Rat brain 
tissues from which RNA was isolated and their developmental stages are indicated at the top of 
each figure. No preparations of total RNA from P35-cortex and adult brainstem were available. 
The rMMS2-probe specifically hybridised with two transcripts, a major 1,7 kb mRNA and a 
minor transcript of approx. 3 kb, which, at the probe concentration applied, was only weakly 
detectable in cerebral cortex and hippocampus at E18 (not shown). The major 1,7 kb rMMS2 
transcript was strongly downregulated in cerebral cortex, hippocampus and cerebellum early in 
postnatal development. In brainstem, expression remained constant until P10 but was 
decreased at P35. In the adult rat, weak expression of rMMS2 could only be detected after 
overnight exposure in the hippocampus. 
3.2.1.4 Transcript expression of rMMS2 in neonatal rat brain 
To further gain insight into the distribution of rMMS2 transcript in rat brain around birth, 
in situ-hybridisation on rat sagittal brain sections was performed at developmental stages 
E20 and P1. 
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Fig. 3-12: Distribution of rMMS2 transcript in rat brain around birth. 
Sagittal brain sections from rats at embryonic day 20 (A) or postnatal day 1 (B and C) were 
hybridised with 500 ng/ml of either antisense (A and B) or sense (C) probe for rMMS2. For 
each picture, two separate photographs of the forebrain and the hindbrain were combined to 
show the entire brain. rMMS2 mRNA is widely expressed in rat brain around birth with 
highest transcript levels being detected in the outer layers of the cerebral cortex, pyramidal 
cells of hippocampal regions CA1-CA3, thalamus (P1), superior (P1) and inferior colliculus of 
the tectum, cerebellar cortex, deep cerebellar nuclei and some brainstem nuclei. 
In fig. 3-12, an overview of rMMS2 mRNA expression around birth is presented in the 
entire rat brain. Hybridisation of a brain section at E20 with the antisense rMMS2-cRNA 
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probe revealed widespread expression of rMMS2, most likely in neurons (see fig. 3-14 and 
3-15 for higher amplifications). Highest levels found in the outer layers of the cerebral 
cortex (cortical plate), pyramidal cells of hippocampal regions CA1-CA3, thalamus, 
superior and inferior colliculus, cerebellum and in a few brainstem nuclei (A and B). In 
cerebellum, deep cerebellar nuclei were stained as well as the cortex. A control section, 
hybridised with a sense rMMS2-cRNA probe under same conditions, did not show any 
significant signal (C). 
3.2.1.5 Downregulation of rMMS2 mRNA in postnatal rat brain 
To confirm rMMS2 downregulation observed in Northern analysis, the spatial and 
temporal distribution of rMMS2-mRNA in brain during postnatal development and 
neuronal differentiation was further examined. rMMS2 expression was therefore studied in 
the CNS at different developmental stages by in situ-hybridisation (Fig. 3-13 to Fig.3-16). 
Sense hybridisations carried out under the same conditions as the antisense experiments 
did not display significant signals. Only at P35 and in the adult rat some background 
staining was detected in the cerebellum and hippocampus. These regions are known to be 
delicate in analysis by in situ-hybridisation as they often exhibit unspecific signals when 
hybridised with sense probes. The signals obtained in cerebellar granule cells and in the 
dentate gyrus of the hippocampus at P35 are therefore likely to be unspecific. Fig.3-13 
illustrates the transcriptional regulation of rMMS2 throughout postnatal development in 
cerebral cortex (A-H), hippocampus (Q-X) and cerebellum (I-P); higher power 
photographs are shown in fig. 3-14 (cortex and hippocampus) and fig. 3-15 (cerebellum). 
In cerebral cortex (fig. 3-13: A-H and fig. 3-14: A-C), a strong staining for rMMS2 could 
be observed in the outer half of the cerebral cortex, most probably corresponding to 
postmitotic neurons of the cortical plate (CP) and subplate. At P5, a signal was observed in 
two cell bands of the cortical plate: the outer band included cells near the pial surface, the 
inner band comprised neurons of middle cortical layers. At P10, rMMS2 expression 
became restricted to neurons of middle layers of the cortical plate (layers 5 and 6). At P35, 
the signal strongly decreased and was further diminished in the adult. In cerebellum (fig. 3-
13: I-P and fig. 3-15: A-C) highest transcript levels were found at P1, in the deep nuclei 
and also in the cortex, where cells of the EGL (premigratory granule cells, precursors of 
Bergman glia and Stellate cells) and of the Purkinje cell layer (PL) expressed rMMS2. At 
P10, a weak staining was still observed in the EGL and in some cells of the deep nuclei. At 
P35 and in the adult, transcript expression was strongly reduced and remained weak in the 
granule cell layer and deep nuclei. In the hippocampus (fig.3-13: Q-X and fig.3-14: D-F), 
the signal was strongest in pyramidal cells of the CA3-region at P1, became weaker at P10 
and was decreased to very low levels at P35. In the adult, rMMS2 expression was absent in 
the entire hippocampal formation. 
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Fig. 3-13: Developmental expression pattern of rMMS2 transcript in rat cerebral cortex, 
hippocampus and cerebellum. 
Sagittal brain sections from rats of the indicated ages were hybridised with 500 ng/ml antisense 
or sense cRNA probe for rMMS2. Bright field photographs from cerebral cortex (A-H), 
hippocampus (Q-X) and cerebellum (I-P) demonstrate a strong transcriptional downregulation 
during early postnatal development. In cerebral cortex, a strong signal was distributed over the 
outer half of the cortical plate at P1 (A), whereas it was restricted to middle cortical layers at 
P10 (C) and expression decreased further until adulthood (E and G). In the cerebellum of a P1-
rat, rMMS2 transcript levels were high in the deep nuclei and somewhat weaker in the 
cerebellar cortex (I). At P10, the signal was decreased in the deep cerebellar nuclei but stayed 
at moderate levels in the external granular layer, EGL (K). At P35 and thereafter, rMMS2 
mRNA levels were hardly detectable (M and O). In hippocampus, highest transcript levels 
were seen in the CA-regions until P10 (Q and S). It seemed that rMMS2 was higher expressed 
in the CA3- than in the CA1-region. At P35, expression in the CA-region was much weaker 
(U) and decreased further until adulthood (W). Hybridisations performed with a sense probe 
for rMMS2 at the same concentration under same conditions did not show any signal until P10. 
However, at P35 and in the adult, a weak signal was found in the cerebellar granule cells and 
dentate gyrus of hippocampus similar to the signals seen with the antisense probe. These 
signals therefore are likely to be unspecific. 
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Fig. 3-14: Higher resolution of rMMS2 transcript expression patterns in rat cerebral cortex and 
hippocampus during postnatal development. 
Transcriptional downregulation of rMMS2 during development (demonstrated in fig.3-13) is 
shown at a higher magnification (20x) in the cerebral cortex (A-C) and the CA3-region of the 
hippocampus (D-F) in rats from developmental stage E20, P5 and P10. Hybridisation 
conditions were the same as described for fig.3-13. At E20, neurons of superficial cortical 
layers were stained for MMS2-RNA (indicated by an asterisk in A). At P5, superficial and 
middle cortical layers were positive (indicated by arrows in B). At P10, the signal has become 
restricted to neurons of middle cortical layers (indicated by an arrowhead in C). In the 
hippocampus, CA3 pyramidal neurons exhibited a strong signal from E20 until P10, whereas 
the granule cells of the dentate gyrus displayed merely weak to moderate MMS2 transcript 
expression (D-E). PS = pial surface, VZ = ventricular zone, DG = dentate gyrus, CA3 = CA3-
pyramidal cells of the hippocampus. 
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Fig. 3-15: Higher resolution of rMMS2 transcript expression in the rat cerebellar cortex during 
postnatal development. 
Transcriptional downregulation of rMMS2 in the cerebellum during postnatal development 
(demonstrated in fig.3-13) is shown at a higher magnification (20x). Hybridisation of sagittal 
brain sections from rats at E20, P5 and P10 was carried out with either 500 ng/ml antisense 
cRNA probe for rMMS2 (A-C) or with 100 ng/ml antisense cRNA probe for Calbindin (D-F), 
which specifically labels Purkinje neurons in the cerebellum. In G-I, control sections were 
stained with cresyl violet in order to better discriminate cellular layers of the cerebellum: PL = 
Purkinje cell layer, EGL = External granular layer, IGL = Internal granular layer. At E20, 
hybridisation with the MMS2-probe (A) resulted in a strong staining of cells located in the PL 
and a moderate staining of cells of the EGL. Hybridisation with the Calbindin probe at E20 (D) 
identifies Purkinje neurons in a thick cellular band underneath the EGL, as they have not yet 
formed a monolayer. At P5, MMS2 transcript expression was still present in neurons of the 
superficial EGL but was reduced in deeper layers of the cerebellar cortex (B): in the PL, 
transcript expression was very weak, whereas cells in the IGL were clearly positive. At P10, 
MMS2 expression has decreased to low levels in the EGL and IGL and was completely absent 
in the PL. 
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Fig. 5-16 demonstrates the developmental regulation of rMMS2 transcript in the brainstem 
(A-F), thalamus (G-L) and tectal area of the mesencephalon (M-R). In brainstem, several 
nuclei (pontine nucleus, facial motor nucleus, superior and inferior olivary nuclei and a 
nucleus in the isthmal region of the cerebellum) were positive at P1, but rMMS2 
expression was strongly downregulated at P10 and completely absent at P35. In the 
thalamus, a strong signal could be observed at P1 in the anterior and intermediate 
thalamus. This expression was strongly downregulated and hardly detectable at P10, no 
hybridisation was found at P35. In the tectal region, highest transcript levels were found in 
the superficial layer of the superior colliculus and in the inferior colliculus at P1. This 
signal was much reduced at P10 with only weak expression being detected in the superior 
colliculus and was completely absent at P35. 
The detailed expression analysis by in situ-hybridisation confirmed that the rMMS2 
transcript was widely expressed in neurons at prenatal and neonatal stages but became 
strongly downregulated in all brain areas after the first postnatal week. This time course 
corresponds well with the loss of the potential for axonal growth and sprouting found in 
many neurons. 
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Fig. 3-16: Developmental expression pattern of rMMS2 transcript in rat brainstem, thalamus and 
tectal region of the mesencephalon. 
Sagittal brain sections from rats of the indicated ages were hybridised with 500 ng/ml antisense 
or sense probe for rMMS2. Bright field photographs from brainstem (A-F), thalamus (G-L) and 
tectal region (M-R) demonstrated a strong transcriptional downregulation during early 
postnatal development. In brainstem, a strong signal was present in several brainstem nuclei at 
P1 (A), which are indicated by arrows: high transcript levels were found especially in the 
pontine nuclei (a), superior olivary nucleus (b), facial motor nucleus (c), inferior olivary 
nucleus (d) and a nucleus in the isthmal region (e). At P10, rMMS2 transcript was still weakly 
expressed in certain nuclei (C), whereas it was completely downregulated at P35 (E). The 
anterior (a) and intermediate (b), but not the posterior thalamus displayed strong rMMS2 
expression at P1 (G). At P10, a signal in the thalamus was hardly detectable (I) and was 
completely absent at P35 (K). In the tectal region at P1 (M), highest transcript expression was 
present in the superficial layer of the superior colliculus (a) and in the inferior colliculus (b) At 
P10, expression was weaker in the entire tectum and became restricted to a thin layer in the 
superior colliculus (O, arrow). At P35, it was completely downregulated (Q). Sense 
hybridisations, performed at the same concentration under same conditions, did not show any 
signal. 
3.2.1.6 Differential regulation of rat CD24 during postnatal development 
CD24 was yet another molecule identified by the cerebellar subtraction approach. It is a 
highly glycosylated protein, which belongs to the large protein family of cell adhesion 
molecules and is attached to the cell membrane by GPI-anchoring (Kay et al., 1991; 
Pirruccello and LeBien, 1986). As CD24 is differentially expressed in the developing 
mouse cerebral cortex (Calaora et al., 1996) and in mouse and rat cerebellum (Kuchler et 
al., 1989) and is downregulated in the adult brain in human, mouse and rat (Poncet et al., 
1996; Shirasawa et al., 1993), examination of its developmental expression pattern was 
performed in the entire brain during the critical period of axonal outgrowth. Northern- and 
in situ-hybridisation analyses (fig. 3-17 to 3-19) were therefore performed using the 
isolated CD24 cDNA fragment as hybridisation probe. Fig. 3-17 shows the temporal 
regulation of the CD24 transcript in developing rat brain by Northern hybridisation. In 
cerebral cortex, hippocampus and brainstem, expression was strongest at E18 and declined 
thereafter. At P10, expression was already very weak if detectable at all. In cerebellum, 
expression was moderate at E18 and stayed until P10 but was absent at P35. In the adult, 
no transcript levels could be detected in neither of the tested samples, even after overnight 
exposure. 
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Fig. 3-17: Northern analysis of rat CD24 mRNA in multiple brain tissues during development. 
The membrane containing 1 µg of total RNA was hybridised with 120 ng/ml of DIG-labelled 
CD24 cRNA probe. Exposure time of the X-ray film was 2 hours (upper panels, a) or overnight 
(middle panels, b). As a control for equal loading of total RNA on each lane, a photograph of 
the ethidium bromide-stained 28S rRNA band is shown (lower panels, c). Rat brain tissues 
from which RNA was isolated and their developmental stages are indicated at the top of each 
figure. The 1,9 kb CD24 transcript was strongly downregulated in cerebral cortex, 
hippocampus and brainstem in the first postnatal week. In cerebellum, transcript levels stayed 
until P10 but were absent at P35 and in the adult. After overnight exposure, slight expression 
could be detected in hippocampus at P10. Yet, in the adult, no expression was apparent in all 
brain regions tested. 
In situ-hybridisation was carried out in order to further study the spatial and temporal 
distribution of CD24 transcript in developing rat brain (fig. 3-18 and 3-19). In fig. 3-18, 
CD24 mRNA expression is presented on sagittal rat brain sections from developmental 
stage E20. Strong expression was found in outer layers of the cerebral cortex, in 
hippocampus, striatum, thalamus, superficial layers of colliculus superior, colliculus 
inferior, cerebellar cortex and deep nuclei and some brainstem nuclei. No signal was 
obtained with the CD24 sense probe. 
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Fig. 3-18: Distribution of CD24 transcript in rat brain at E20. 
Sagittal brain sections from rats of developmental stage E20 were hybridised with 500 ng/ml 
antisense (upper panel) or sense probe (lower panel) for rat CD24. High transcript levels were 
present in the outer layers of the cerebral cortex, in the striatum, thalamus, hippocampus, 
superficial layers of colliculus superior, colliculus inferior, cerebellar cortex and deep nuclei 
and some brainstem nuclei (upper panel). Hybridisation with the sense probe did not display 
any signal (lower panel). 
The widespread expression described for E20 was strongly reduced during CNS 
maturation with the CD24 transcript being completely downregulated in most regions at 
P10, except in the cerebral cortex and cerebellum: a shift occurred in cerebral cortex from 
a strong signal in the outer layers at E20 to a weaker signal in the deeper layers at P10, 
which was absent in the adult, similar to what was described in the mouse (Calaora et al., 
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1996, data not shown). In the cerebellum, CD24 transcript is differentially expressed 
during postnatal development, which is illustrated in fig. 3-19. At E20 (A and B), high 
transcript expression was present in the deep cerebellar nuclei and in the Purkinje cell layer 
of the cerebellar cortex. In addition, very strong expression was observed in a brainstem 
nucleus in the isthmal region of the cerebellum. At P4, deep cerebellar neurons did not 
express CD24 transcript any more and expression in the Purkinje cell layer was much 
weaker and was hard to distinguish (D and E). Instead, cells of the EGL were now stained. 
This expression pattern remained fairly constant until P10 (G and H) but was somewhat 
weaker. In the adult (J and K), although CD24 expression was further downregulated, low 
expression was maintained in Purkinje neurons. 
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Fig. 3-19: Expression pattern of rat CD24 mRNA in cerebellum during development. 
Sagittal brain sections from rats of the indicated ages were hybridised with 500 ng/ml antisense 
(left and middle panels) or sense probe (right panels) for rat CD24. Bright field photographs 
illustrate the developmental regulation of the CD24 transcript in cerebellum beginning at E20 
until adulthood. Photographs of the middle panels show a higher magnification of those of the 
left panels. Highest expression was found at E20 in Purkinje cells of the cerebellar cortex and 
in deep cerebellar nuclei (A and B). Strong expression could also be detected in a nucleus of 
the isthmal region of the cerebellum (A). At P4 (D and E), expression in the deep cerebellar 
nuclei was not detectable anymore and had decreased to low levels in the Purkinje cell layer 
(arrows in E). In contrast, cells of the EGL were now positive. This pattern remained fairly 
constant at P10 but was somewhat weaker (G and H). In the adult (J and K), low transcript 
levels were still present in Purkinje cells (arrows in K), but expression was absent in the 
molecular layer. Sense hybridisations (right panels) did not display any signal. 
3.2.1.7 Analysis of further clones of the cerebellar subtraction 
In addition to the above-described molecules, further subtracted clones were examined by 
Northern- and in situ-hybridisation analysis. For varying reasons, these analyses were not 
continued. This is detailed in table 3-2, which presents a list of such molecules together 
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with the performed analyses and the obtained results. On the right side, the reasons for not 
continuing the analysis are indicated. 
Name of molecule Performed analysis 
Results of analysis /  
Reasons for stopping the analysis 
Neuronal surface 
glycoprotein MRC 
OX-2 
NB and isH
Transcript expression peaked early postnatally, 
declined until P10 and was further downregulated 
until P35 in cortex, cerebellum, hippocampus and 
brainstem. In hippocampus, stronger expression was 
observed in the CA-region than in the dentate gyrus 
at P4 and P10. IsH confirmed the expression pattern 
that was previously described in cerebellum during 
postnatal development. Background staining with 
the sense-probe.  
EST-clone nr. 12 isH Background staining with the sense-probe and a strong hybridisation gradient on the slide 
Unknown clone nr. 13 isH Only very weak and unspecific staining 
GPI transamidase: isH Damage of brain slices and unspecifity 
EST-clone nr. 20 isH 
Transcript was specifically expressed in cerebellum, 
brainstem and cortex, but expression seemed not to 
be regulated in brain during postnatal development. 
Ras-GAP isH Background staining with the sense-probe and unspecific staining with the antisense-probe 
Snurportin-1 isH Unspecifity 
TAR DNA-binding 
protein TDP-43 isH Unspecifity 
Unknown clone nr. 29 isH No signal 
EST-clone nr. 35: isH Strong, unspecific signal with the sense-probe 
SCG-10 and Stathmin isH 
Both probes confirmed the expression patterns that 
were previously described in developing rat brain. 
Results are already published. 
Table 3-2: Expression analysis and evaluation of further clones enriched by the cerebellar 
subtraction approach. 
This table presents a list of subtracted clones from E18-cerebellum that were examined by 
Northern- and in situ-hybridisation, but for which these analyses were not included in the 
Results section. Results of the expression studies and various reasons why these molecules 
were not further investigated are given in the right column. 
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3.2.2 Suppression Subtractive Hybridisation with rat entorhinal cortex at 
 two developmental stages 
In an attempt to identify genes implicated in hippocampal development and establishment 
of the perforant path, a similar subtraction approach as performed in rat cerebellum was 
applied for rat entorhinal cortex at two developmental stages. Comparable to the age-
dependent decrease in axon growth in rat cerebellum, axonal outgrowth and regeneration is 
lost in the early postnatal period in the entorhinal cortex. This was studied in vitro in rat 
and mouse by diverse groups, who demonstrated that maturing entorhinal fibers lose their 
ability to grow towards the dentate gyrus and CA-region of the hippocampus in the second 
postnatal week (Li et al., 1995; Prang et al., 2001; Woodhams et al., 1993). Based on these 
studies, the following developmental stages were determined for the entorhinal subtraction 
approach: postnatal day 0 (P0) as the axon-elongating stage and P10 as the time point, 
when axonal outgrowth is considerably diminished. By subtraction of EC-P10 from EC-P0 
transcripts, genes that are stronger expressed at birth but which are downregulated at P10 
were enriched in the generated subtractive library. 45 subtracted clones were randomly 
chosen for sequence analysis. By comparison with the databases, 13 clones were found to 
be identical to known rat genes or highly similar to homologues in other species. 7 
sequenced cDNA fragments were completely unknown and 11 clones corresponded to rat 
EST sequences. Four sequences were found twice. Remaining clones (10) didn’t contain a 
specific insert or produced defective sequence results. Proteins encoded by known genes 
were classified into the same groups of proteins like in the cerebellar subtraction: (1) 
transcription factors and other nuclear proteins, (2) cytoskeletal proteins, (3) signalling 
molecules, (4) enzymes, metabolic proteins and transporters, (5) cell surface molecules and 
(6) growth associated proteins. The classification is shown in table 3-3. A few of the 
subtracted genes are already known to be downregulated during brain development on 
either transcript or protein level, which is indicated by an asterisk (*) in table 3-3. 
The obtained sequences confirm that the generated entorhinal subtractive library may serve 
as a promising tool to identify genes which are strongly expressed in differentiating 
neurons of the CNS during formation of axons, but which are downregulated later in 
development. The G-protein coupled receptor SREB-2, 5 EST-clones and two unknown 
genes, which were isolated by the subtraction approach, were further analysed by 
Northern- and in situ-hybridisation. For several reasons, which were similar to those of the 
cerebellar subtraction approach (see table 3-2, section 3.2.1.7) and which are indicated in 
the following résumé, these studies did not lead to consistent results so far. 
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Classification groups Protein products of identified genes 
 
 
transcription factors and other nuclear proteins human transcriptional activator hBRM 
 rat nuclear transport factor-2, NTF-2 
 rat RNA-binding polypeptide RA301 
  
cytoskeletal proteins rat α-tubulin 
 rat cytoplasmic form of χ-actin 
  
signalling molecules mouse arsenite-inducible RNA-associated protein AIRAP 
 rat hfb2 protein (Bdm2) * 
  
enzymes, metabolic proteins and transporters rat tricarboxylate carrier-like protein 
 human protein kinase WNK3 
 rat syntaxin 7 
  
cell surface molecules rat G-protein coupled receptor SREB2 
  
growth associated proteins rat GAP-43 * 
 rat stathmin * 
  
Table 3-3: Classification of protein products of genes, enriched in a subtractive library of rat 
entorhinal cortex at P0. 
Specified in this list are all clones, which were identical to known rat genes or displayed strong 
similarity to homologous genes in mouse or human (13 of 45 sequenced clones). Proteins that 
were known to be downregulated during brain development either on transcript or protein level 
are indicated by an asterisk (*). 
3.2.3 Short Résumé 
The Subtractive Suppression Hybridisation approaches resulted in the enrichment of 
multiple rat cDNAs and allowed the identification and characterisation of a novel rat gene, 
rMMS2, which is developmentally regulated in rat brain. Expression patterns of further 
subtracted genes were analysed by Northern blotting and in situ-hybridisation studies. As 
was demonstrated for rMMS2, the transcripts of two more clones identified in the 
cerebellar subtraction assay, CRHSP-24 and CD24, were widely distributed in neonatal 
brain during axon outgrowth but were extensively downregulated during postnatal 
development and were hardly expressed in the adult. These three proteins were therefore 
good candidate molecules, which might play a role in neuronal differentiation. Other 
clones from both subtraction approaches were examined as well, some of which indicated a 
higher transcript expression around birth compared to later stages of development, e.g. 
MRC OX-2. Nevertheless, various difficulties impeded the accomplishment of these 
expression studies and prevented an efficient screening of the generated subtraction 
libraries: first, brain slices from young rats (of embryonic or early postnatal age) suffered 
much stronger from the long in situ-hybridisation procedure than more mature rat brains 
and were sometimes severely disrupted. To overcome this problem, experiments were 
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similarly performed with perfused animals in order to work with tissue that was more 
robust. Yet, as sensitivity was much decreased under these conditions and experiments 
with many subtracted molecules resulted in only weak staining, in situ-hybridisation 
analyses were carried on with postfixed tissue as before. Furthermore, control experiments 
with corresponding sense-probes often resulted in background staining, therefore 
preventing a correct interpretation of the antisense-signals. Other molecules seemed not to 
be suitable for examination by Northern blotting or in situ-hybridisation and produced no 
or only unspecific signals. Finally, expression of genes like SCG-10 or stathmin were only 
used as positive candidates for downregulation during development but were not further 
examined as their expression patterns were previously studied and these results are already 
published. 
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4 Discussion 
In the present studies, it was searched for genes which are highly expressed in CNS 
neurons during axonal outgrowth and which are significantly downregulated in these 
neurons during postnatal maturation when the growth-potential progressively declines. 
Genes associated with axon growth during development might also be important for 
determining the regenerative potential of neurons after nerve injury.  
The idea that genes, transiently expressed during development and associated with 
developmental axonal outgrowth, might be re-induced after a nerve lesion and thus might 
contribute to axonal regeneration is supported by several studies. In the PNS, 
neurotrophins like NGF, NT-3, NT-4/5 and BDNF are good examples as they are 
expressed both, during neuronal differentiation when neurotrophic factors are crucially 
required for growth of peripheral nerves and development of dendritic arbors, and after 
peripheral nerve lesion, thus contributing to axonal regeneration in the PNS (reviewed by 
Bibel and Barde, 2000; Cai et al., 1999; Goldberg et al., 2002a; Markus et al., 2002). There 
are also candidate molecules in the CNS, whose expression is similarly regulated during 
formation of neuronal circuits during development and after lesion in the adult CNS. The 
growth-associated proteins GAP-43 and Cap-23, for example, which are expressed in 
growth cones of axon-extending CNS neurons and are downregulated during postnatal 
development in many brain regions, are re-expressed in some neurons after lesion in which 
they are associated with regenerative sprouting (Aigner et al., 1995; reviewed by Benowitz 
and Routtenberg, 1997; Bomze et al., 2001; Frey et al., 2000; Skene and Willard, 1981b). 
Moreover, the two cell adhesion molecules L1 and polysialylated neural cell adhesion 
molecule (PSA-NCAM) are developmentally regulated, promote neurite elongation and are 
re-induced in certain lesioned CNS neurons, which is associated with regenerating and / or 
sprouting axons (reviewed by Aubert et al., 1995). Furthermore, rho-GTPases are known to 
play a role in signal transduction of growth-controlling molecules during development and 
were shown to be involved in transducing inhibitory signals from myelin components in 
the mature CNS, thereby preventing severed fiber tracts from regenerating (Lehmann et al., 
1999; reviewed by Patel and Van Vactor, 2002). Cyclic nucleotides such as cAMP and 
cGMP similarly exert a growth-promoting function during development and regeneration 
(Cai et al., 1999; Cui et al., 2003; Mizuhashi et al., 2001; Neumann et al., 2002; Qiu et al., 
2002; Song et al., 1997).  
These findings suggest that at least some aspects of axon pathway formation are similarly 
controlled during neuronal development and regeneration, which emphasizes the 
importance of searching for growth-associated genes during the axon-extending period of 
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developing CNS neurons. A better understanding of developmental events may permit to 
address more accurately the challenge of axonal re-growth in the adult mammalian CNS.  
Previously, organotypic slice cultures from cerebellum or entorhinal cortex and 
hippocampus had been established in the mouse and rat, which allow to extensively study 
the formation of neuronal connections in the CNS in vitro (Dusart et al., 1997; Li et al., 
1995; Prang et al., 2001; Woodhams et al., 1993). Moreover, this culture model can serve 
well for investigations of the regenerative capability of Purkinje neurons and entorhinal 
pyramidal cells as both projections show a similar maturation-dependent growth-behaviour 
as in vivo. For both neuronal populations, the period of extensive axon growth as well as 
the time when the growth potential declines rapidly was determined (Dusart et al., 1997; Li 
et al., 1995; Prang et al., 2001; Woodhams et al., 1993). This culture model thus would 
allow the examination of candidate molecules concerning their association with axon 
growth or regeneration. Purkinje neurons and entorhinal pyramidal cells, respectively, 
were therefore chosen for analysis of their gene expression patterns at the time point of 
maximal axonal outgrowth during development. Two different approaches were used in 
order to identify genes highly expressed in these two neuronal populations during early 
differentiation processes. The first approach, degenerate PCR with oligonucleotides 
specific for transcription factor classes, focused on the identification of molecules with a 
regulatory function that might control the expression of several axon growth-associated 
downstream target genes. The second approach, subtractive suppression hybridisation 
(SSH), though considering various molecule classes, confined the search on those genes 
that were downregulated during neuronal maturation. 
4.1 Degenerate PCR-approach 
Degenerate PCR with primers for DNA-binding domains of POU-, Hox-, bHLH-, zinc 
finger-, ETS- and Forkhead classes of transcription factors was applied in order to amplify 
members of these gene families from rat entorhinal cortex and cerebellum during the 
period of extensive axonal outgrowth, P0 and E18, respectively. Successful PCR 
amplifications were achieved in both brain regions tested with the POU and zinc finger 
primers. Employing degenerate POU primers, two class III family members, brain-2 (brn-
2) and brain-4 (brn-4), were amplified. The brain factors seem to be the predominant POU 
domain transcription factor family members expressed in brain at the time of neuronal 
differentiation as a high redundancy was obtained in the degenerate PCR with POU-
primers. 35 analysed POU cDNAs yielded no more than two different POU factors. Brn-2 
and brn-4 are strongly expressed and broadly distributed in the brain early on during 
development and continue to be expressed in adulthood (Alvarez-Bolado et al., 1995; He et 
al., 1989; Le Moine and Young, 1992; Mathis et al., 1992; Schreiber et al., 1993). In 
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contrast, the type IV brain factors, including brn-3a, brn-3b and brn-3c, have a more 
distinct distribution in the CNS and appear to regulate the development of certain specific 
sensory functions (He et al., 1989; reviewed by McEvilly and Rosenfeld, 1999). As the 
expression pattern and function of brn-2 and brn-4 are already well studied during brain 
development and in the adult (Hagino-Yamagishi et al., 1997; He et al., 1989; Le Moine 
and Young, 1992; Malik et al., 1997; Mathis et al., 1992; reviewed by McEvilly and 
Rosenfeld, 1999; Nakai et al., 1995; Rosenfeld et al., 1996; Schonemann et al., 1995; 
Sharp and Morgan, 1996), no further examinations of these molecules were performed. 
The identification of transcription factors of the zinc finger family contained some 
limitations although the amplification of zinc finger domain containing genes and 
generation of the characteristic “ladder” banding pattern were successful. As the region 
amplified by degenerate zinc finger primers was highly conserved and the sequence-span 
between the two primer binding sites quite short, the amplified PCR-fragments were 
elongated by 3’-RACE with the aim to obtain DNA regions outside the conserved domains 
which were specific for individual zinc finger factors. This should allow for reliable 
comparisons with sequences present in the databases and generation of sequence-specific 
RNA-probes for hybridisation. Yet, RACE is an intricate method that is useful for 
identification of the ends of a distinct cDNA-fragment but is not practical for elongation of 
a whole set of PCR-amplified zinc finger cDNAs. Accordingly, elongation of the 3’-end of 
amplified zinc finger cDNAs succeeded only in one case. Yet, hybridisation with this 
probe did not result in specific signals. However, the databases had been considerably 
enriched with additional information especially about mammalian sequences in the last 
years, which would render a future identification of zinc finger transcription factors by 
searching for overlapping sequences with highly conserved sequence stretches much 
easier. As the RNA probe generated for the one identified zinc finger cDNA did not result 
in specific hybridisation signals and the RACE-method did not seem to be effective in 
yielding multiple zinc finger sequences outside the conserved region, identification of zinc 
finger transcription factors was not further pursued. 
Use of other degenerate oligonucleotides resulted in either no amplification products or in 
unspecific amplification of multiple cDNA fragments. This might be due to the fact, that 
degenerate primers were designed such that they were convenient for amplification of 
different subclass members of transcription factor families, which involves a higher degree 
of degeneracy. Hox genes, for example, all contain related homeodomain sequences, which 
can be classified into at least 30 distinguishable classes (Kappen et al., 1993). Sequences 
belonging to the same class are highly similar to each other but there are no obvious close 
relationships between the separate classes (Banerjee-Basu and Baxevanis, 2001; Kappen et 
al., 1993). The same is true for other transcription factor families, e.g. the ETS factors 
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(Janknecht and Nordheim, 1993; Wasylyk et al., 1993), bHLH proteins (reviewed by 
Bertrand et al., 2002; Massari and Murre, 2000) and Forkhead proteins (reviewed by 
Carlsson and Mahlapuu, 2002; Kaestner et al., 2000). With the intention to achieve a broad 
binding of the degenerate primers to members of different subclasses within one 
transcription factor family, degeneracy of the designed oligonucleotides might have 
become too high. This would explain the low yield that was obtained in the degenerate 
PCR using oligonucleotides for bHLH, HOX, ETS and FKH genes. Conversely, the POU-
primers used in the described approach were specific only for one subclass of POU 
proteins (class III), leading to the sole amplification of class III-proteins and thereby 
confining the yield markedly. One strategy to circumvent this problem in the future would 
be to use sets of degenerate primers in the PCR for one transcription factor family, varying 
in one or two nucleotide triplets and thus amplifying the conserved domain of factors 
belonging to diverse subclasses. In addition, efficiency of degenerate PCR might also be 
increased by using primers tagged by unrelated sequences, e.g. derived from RNA-
polymerase promotors, which can be bound by a second primer pair, e.g. promotor 
primers. This allows a higher annealing temperature in the second PCR thereby leading to 
a reduction of background and enhancement of specificity as demonstrated in a PCR with 
degenerate zinc finger primers (Agata et al., 1998).  
To conclude, the paradigm of the degenerate PCR aimed at the identification of 
transcription factors, which were highly expressed in the rat cerebellum and entorhinal 
cortex, respectively, at the time of substantial axonal outgrowth. Further interest lied in the 
spatial and temporal distribution of identified transcription factors in the developing brain, 
which implicated subsequent expression analyses of the PCR-amplified cDNAs by 
Northern- and in situ-hybridisation experiments. Although the degenerate PCR approach 
was proficient for amplification of conserved regions of POU-and zinc finger transcription 
factors, it was not efficient in producing various template sequences which could be used 
for the generation of specific probes for subsequent expression studies of each amplified 
transcription factor. 
4.2 Suppression subtractive hybridisation (SSH) 
The method of SSH was applied with the aim of identifying differentially expressed genes, 
which are highly expressed in the postnatal rat brain during the period of extensive axonal 
outgrowth and whose expression decreases with progression of development. By this 
means, it seemed very promising to find genes that might play a role in neuronal 
differentiation processes during postnatal development and might possibly be involved in 
axon growth. Indeed, a considerable part of our subtracted, known genes had previously 
been examined and was shown to be downregulated during brain development (indicated 
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by an asterisk in tables 3-1 and 3-3 in sections 3.2.1.and 3.2.2, respectively). mRNA 
expression of p19/stathmin, for example, has been extensively studied in the rat and a 
greater abundance in newborn than in adult brain has been demonstrated (Sugiura and 
Mori, 1995). Thymosin β4 shows high expression during granule cell migration and 
parallel fiber elongation in rat cerebellum early in postnatal development but expression 
declines thereafter (Border et al., 1993; Lin and Morrison-Bogorad, 1990). The neuronal 
surface glycoprotein OX2 as well is differentially regulated and displays highest protein 
levels during axogenesis in rat cerebellum (Morris and Beech, 1987). Developmentally 
regulated molecules were also present in the entorhinal subtraction, e.g. GAP-43, which is 
one of the best characterized proteins that is associated with axon growth and regeneration, 
and whose expression correlates well with process outgrowth during development and 
lesion-induced sprouting (Aigner et al., 1995; Buffo et al., 1997; Caroni, 1997; Laux et al., 
2000; reviewed by Skene, 1989; Skene and Willard, 1981b). Another molecule, Bdm2, is 
more abundantly expressed in fetal than in adult brain (Nishinaka et al., 2000). Though few 
of the subtracted developmental molecules represent early markers like nestin, which is 
strongly expressed in stem cells or proliferating cells, numerous genes are upregulated later 
during development, correlating well with the period of extensive axon growth, and some 
of them were shown to be associated with axonal regeneration. For instance, SCG-10 
mRNA expression is localized within growing neurites, peaks during neurite outgrowth 
and is associated with axon regeneration (Hannan et al., 1996; Mason et al., 2002; Pellier-
Monnin et al., 2001). HB-GAM expression is high in developing axonal projections 
(Rauvala et al., 1994) and stathmin is developmentally regulated during axon growth in the 
rat and is transiently induced after EC-lesion (Brauer et al., 2001).  
These results confirm, that the applied strategy was very efficient for enrichment of 
differentially regulated genes that are expressed more abundantly in developing than in 
mature CNS. The two subtracted libraries thus provide valuable tools to identify candidate 
molecules that are strongly expressed in rat brain around birth and might play a role in 
axonal outgrowth. In the following, the temporal and spatial expression pattern and 
possible functional significance of those identified molecules, which were studied in more 
detail, will be discussed.  
4.3 CD24 
One of the identified genes in the cerebellar subtraction approach was the cell adhesion 
molecule CD24, which is developmentally regulated in brain and can either stimulate or 
inhibit axon outgrowth, depending on the cell type and on other cell adhesion molecules 
expressed by these cells (Kleene et al., 2001; Kuchler et al., 1989; Nedelec et al., 1992; 
Shewan et al., 1996; Shirasawa et al., 1993). Rat CD24 is a highly glycosylated protein of 
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31 kDa that is attached to the cell membrane via a glycosyl phosphatidylinositol (GPI) 
anchor and is, in addition to neuronal cells, expressed by cells of the hematopoietic 
lineage, keratinocytes, epithelial cells and carcinoma cells (Jackson et al., 1992; Kay et al., 
1991; Kay et al., 1990; Magnaldo and Barrandon, 1996; Shirasawa et al., 1993; Wenger et 
al., 1991). It is widely expressed in the nervous system during embryonic development and 
displays strongest expression in embryonic brain, spinal cord, dorsal root ganglia, retina 
and on optic nerve fibers (Shewan et al., 1996; Shirasawa et al., 1993). In the adult brain, 
CD24 is dramatically downregulated (Nedelec et al., 1992; Poncet et al., 1996; Shirasawa 
et al., 1993) and expression persists only in regions of secondary neurogenesis, the 
subventricular zone of the lateral ventricle and the dentate gyrus (Calaora et al., 1996).  
In the present study, CD24 expression was examined in various brain regions in the late 
embryonic and early postnatal development of the rat by Northern blotting and in situ-
hybridisation. Northern analysis revealed a strong decline of CD24 transcript in cerebral 
cortex, hippocampus and brainstem between E18 and P10. This is in accordance with 
previous studies in the mouse, which demonstrated that CD24 protein levels decrease in a 
similar time course in the forebrain (Calaora et al., 1996; Nedelec et al., 1992). Moreover, 
in the embryonic rat, CD24 was shown to be exclusively expressed in postmitotic neurons 
of the neuroepithelium, which were devoid of BrdU incorporation that selectively labels 
proliferating cells (Shirasawa et al., 1993).  
The present Northern analysis further revealed CD24 transcript levels in the cerebellum 
until P10 with strongest expression at P0, but no detection was found at P35. In situ-
hybridisation confirmed this temporal regulation and demonstrated that, whereas CD24 
mRNA was strongly expressed in the Purkinje cell layer and deep cerebellar nuclei at E20, 
expression decreased markedly during early postnatal development, became restricted to 
the external granular layer and further diminished with increasing age. This does not 
entirely match previous immunhistochemical studies (Calaora et al., 1996), in which was 
noted that CD24 protein expression in the mouse cerebellum was low before birth, 
increased between P0 and P6, declined thereafter and had disappeared around P10. Kuchler 
et al. observed a transient expression of CD24 protein in postmitotic, pre-migratory granule 
cell precursors in the internal part of the external granular layer, on parallel fibers and in 
the white matter of the developing cerebellum in rat and mice, but did not detect 
expression in Purkinje cells (Kuchler et al., 1989). This might be due to the later time point 
of their developmental studies, starting at P5, when CD24 transcript levels in Purkinje cells 
are already substantially decreased. CD24 might be expressed by Purkinje neurons around 
birth and transported into the axonal compartment where it might be anchored to the cell 
membrane. This would explain the intense immunostaining of axonal tracts in the 
cerebellar white matter and the lack of labelling of Purkinje cell bodies described by 
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Kuchler et al. between P5 and P15 (Kuchler et al., 1989). Moreover, the faint staining of 
Purkinje cells in the adult (see fig. 3-19, J and K) is consistent with the finding by Kuchler 
et al. that the cerebellar white matter is still weakly positive for CD24 protein in the adult 
mouse (Kuchler et al., 1989). The strong transcription of CD24 by deep cerebellar neurons 
and cells at the isthmal region of the cerebellum detected at E20 (see fig. 3-19, A and B) 
could contribute to the intense immunostaining found on axons in the cerebellar white 
matter by Kuchler et al, too.  
Although the precise function of CD24 in the nervous system has not yet been determined, 
its transient expression by postmitotic neurons and on developing axon tracts during 
neuronal migration and axonal elongation suggests that it might play a role in these 
processes during development (Calaora et al., 1996). This was confirmed by experiments 
with dissociated, cultured neurons, in which CD24 was demonstrated to exert differential 
effects on neurite outgrowth, depending on the neuron type and on the developmental age 
(Kleene et al., 2001; Shewan et al., 1996). Interestingly, Kuchler et al. found that CD24 
decreased in the cerebellar white matter during myelination. In addition, CD24-deficient 
mice revealed enhanced proliferation in regions of secondary neurogenesis, which suggests 
a role for CD24 in negatively regulating cell proliferation in these zones by either 
maintaining precursor cells in a quiescent state or initiating differentiation (Belvindrah et 
al., 2002). Heterophilic interaction was proposed as the mode of action of CD24 since GPI-
anchored CD24 lacks an intracellular domain and therefore itself cannot transduce signals 
from the extracellular milieu to the intracellular compartment. CD24 was shown to interact 
with another cell recognition molecule in neurons, the glycoprotein L1, thereby activating 
the signal transduction pathway of L1 (Kadmon et al., 1995; Kleene et al., 2001). 
Moreover, it was found that glycan chains and sialylation on the CD24-core peptide play 
an essential role for exertion of the differential effects of this molecule on neurite 
outgrowth (Kleene et al., 2001).  
The present results clearly show that CD24 is massively transcribed in the rat cerebellum 
before birth and that Purkinje neurons, deep cerebellar neurons and neurons from an 
extracerebellar nucleus are the main regions of synthesis. Moreover, it is illustrated that 
CD24 transcripts are significantly downregulated in these neurons between E20 and P4, 
when their axonal connections are established. 
4.4 rCRHSP-24 
Suppression subtractive hybridisation further identified the transcript for rCRHSP-24, a 
protein which had not previously been associated with a differential expression in the 
developing rat brain during the period of extensive fiber outgrowth. rCRHSP-24 was 
known in the rat before and its mRNA was previously identified (Groblewski et al., 1998). 
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Yet, the identified cDNA fragment for CRHSP-24 first did not match known mRNAs in 
the sequence databases, as it constituted the 3’ -untranslated region adjacent to the 
transcript’s polyA tail whereas the known rat CRHSP mRNA in the database comprised 
only the coding region of this transcript. This demonstrates that the inability to find 
sequence database matches for some of the subtracted clones (29 cases in total for both 
subtraction approaches) could be a consequence of targeting the polyA tail of mRNAs with 
the suppression subtractive hybridisation approach. These clones, as turned out for 
CRHSP-24, might represent the untranslated regions of a characterized mRNA whose 
sequence in this region is unknown. Concerning CRHSP-24, the identified clone was found 
to be the 3’-untranslated region of the rat transcript because of its strong homology to the 
full-length mRNA in the mouse. This emphasizes that for those subtracted clones, which 
did not match any known sequences in the databases, screening in the EST-divisions of the 
databases for overlapping rat cDNA sequences and use of these in subsequent searches 
might be helpful to identify additional known mRNAs among the subtracted clones.  
In Northern analysis, two CRHSP-24 transcripts of 2,9 and 1,7 kilobases were detected in 
various rat brain tissues from late embryonic development until adulthood. In previous 
studies, Groblewski et al. examined CRHSP transcript expression in multiple adult rat 
tissues, including adult brain, and noted that in all tissues tested, two transcripts of 2,9 kb 
and 0,7 kb, respectively, were expressed (Groblewski et al., 1998). The 2,9 kb-transcript 
most probably corresponds to the full length CRHSP-24 mRNA in rat since a full length 
mRNA for CRHSP-24, which is similar in size (2847 bp) to the 2,9 kb transcript, is 
identified in the mouse (accession number: AK004711). Whereas the 2,9 kb transcript 
detected in the present Northern analysis is consistent with the results from Groblewski et 
al., detection of an additional 1,7 kb transcript is not. It can be supposed that both different 
transcripts arise by alternative splicing as a search in the databases of rat genomic 
sequences revealed the existence of two intron sequences in the coding parts of the rat 
CRHSP-24 gene thus leading to the generation of two distinct proteins. Yet, Groblewski et 
al. demonstrated only a single 24-kDa protein in multiple tissues including brain by 
immunoblotting with a polyclonal antiserum raised against full-length CRHSP-24 protein. 
It is thus likely that the protein generated from the smaller transcript might differ in its 
epitopes from the full-length protein, thus preventing it from recognition by the polyclonal 
antiserum used by Groblewski et al. Alternatively, the smaller transcript might also be 
unstable or posttranscriptionally regulated and translation of this mRNA might be 
repressed. However, this does not explain the discrepancy between the two different 
transcript sizes (0,7 kb and 1,7 kb) for the smaller mRNA species detected by Groblewski 
et al. and in the present studies.  
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Expression analysis of CRHSP-24 by Northern hybridisation at different developmental 
stages revealed that the larger of the two transcripts is clearly downregulated during 
postnatal development and is only weakly expressed in adult brain tissues. Although 
Groblewski et al. clearly detected the 2,9 kb CRHSP-24 transcript in the adult brain, 
expression levels were markedly weaker compared to levels in other tissues such as liver or 
lung and quantity of RNA blotted was much higher.  
rCRHSP-24, initially isolated from rat pancreas, is a calcium-regulated phosphoprotein and 
a substrate for the protein phosphatase calcineurin (Groblewski et al., 1998). It contains a 
conserved cold shock DNA/RNA-binding domain that was originally discovered in 
bacterial cold shock proteins (Groblewski et al., 1998). Prokaryotic and eukaryotic proteins 
containing such domains are believed to function as RNA chaperones in prokaryotes and 
as transcriptional and translational regulators in eukaryotes (Jones and Inouye, 1994). 
CRHSP-24 was proposed to modulate expression of stage-specific mRNAs in mouse testis 
during differentiation of spermatids into spermatozoa by complexing with the Styx /dead 
phosphatase protein (Wishart and Dixon, 2002). CRHSP-24 hence might be a calcium-
stimulated regulator of transcriptional or translational gene expression. As CRHSP-24 
transcript is highly expressed in brain of embryonic and newborn rats and is strongly 
downregulated during early postnatal development in cortex and hippocampus and later in 
development in cerebellum and brainstem, it might be implicated in Ca2+/calcineurin-
mediated signal transduction in the developing brain and might exert repression or 
stimulation of gene expression during neuronal differentiation. Since the 
calcium/calmodulin-regulated protein phosphatase calcineurin, which dephosphorylates 
CRHSP-24 following a rise in free cellular calcium (Groblewski et al., 1998), is expressed 
in many developing rat brain regions not until P4 (Polli et al., 1991), other mechanisms are 
likely to regulate activation of CRHSP-24, too. This is consistent with the finding of 
Groblewski et al. that CRHSP-24 is constitutively dephosphorylated by a phosphatase 
other than calcineurin in pancreatic acinar cells (Groblewski et al., 1998). It therefore 
would be an interesting task to identify binding partners of CRHSP-24 in the brain, 
examine its intracellular localization and elucidate its function in neuronal development. 
4.5 rMMS2 
Another molecule identified by the cerebellar subtraction approach was rMMS2. rMMS2 is 
a novel rat gene that was first characterized in the rat in this study, and which was first 
shown to be differentially regulated during postnatal brain development. Northern 
hybridisation revealed a major 1,7 kb rMMS2 transcript in rat cerebral cortex, 
hippocampus, cerebellum and brainstem and a minor transcript, 2,7-3,7 kb in size, which, 
however, was only observed in cerebral cortex and hippocampus at E18 with the cRNA 
Discussion 
 
80
probe concentrations used in the present studies. Several transcripts were also 
demonstrated in adult mouse brain, with a major band at 1,4 kb (Franko et al., 2001), 
whereas a single transcript (1,5 kb) was observed in human tissues (Xiao et al., 1998). The 
1,7 kb transcript, which seems to be the major transcript expressed in the rat CNS, is likely 
to be generated by alternative splicing as the rat gene for rMMS2 consists of several exons. 
Northern analysis at different developmental stages demonstrated a strong downregulation 
of the 1,7 kb rMMS2 mRNA during postnatal development and neuronal differentiation 
with only weak expression in adult brain. This is in line with the human homologue, which 
was hardly detectable in adult brain (Xiao et al., 1998), but is in contrast to the mouse 
MMS2 transcript that was reported to be strongly expressed in adult brain (Franko et al., 
2001).  
rMMS2 belongs to the family of ubiquitin-conjugating enzyme variants (UEVs), which are 
highly conserved proteins (Villalobo et al., 2002) that share structural similarity with 
ubiquitin-conjugating E2 enzymes (Ubcs) but lack the critical cysteine residue essential for 
the catalytic activity and, in vitro, do not transfer ubiquitin to protein substrates in the 
second step of ubiquitination (Franko et al., 2001). Yeast MMS2 was the first UEV that 
had been identified (Broomfield et al., 1998). It plays a role in error-free DNA 
postreplication repair to limit spontaneous and damage-induced mutagenesis and is 
transcriptionally upregulated in response to DNA damage (Broomfield et al., 1998; Ulrich, 
2001). Mouse and human MMS2 proteins are able to complement the mms2 null mutant in 
yeast and therefore seem to act in the same postreplication repair pathway as the yeast 
counterpart (Franko et al., 2001; Xiao et al., 1998). MMS2 of yeast, mouse and human 
were shown to associate with the E2 enzyme Ubc13, which results in assembly of novel 
polyubiquitin-chains for DNA-repair (Ashley et al., 2002; Hofmann and Pickart, 1999; 
McKenna et al., 2001; Torres-Ramos et al., 2002). Yeast MMS2 and to a lower level also 
human MMS2 are capable of transcriptionally activating the promotor for the c-fos proto-
oncogene (Xiao et al., 1998), whose expression is necessary for protection of cells against 
DNA damaging agents (Kaina et al., 1997). Human MMS2 was also isolated as enterocyte 
differentiation promoting factor EDPF-1 (EMBL/GenBank/DDBJ databases, Accession 
number: U62136, Faria J, 1999), but the function of MMS2 during differentiation was not 
examined. In summary, MMS2 plays a role in DNA repair and is possibly involved in 
ubiquitination. It might exert these functions by formation of heterodimers with Ubcs or E3 
ubiquitin ligases, thereby modifying their intracellular localization, substrate specifity and 
activity. This could be a possible strategy of eukaryotic cells to increase diversity and 
selectivity in ubiquitin conjugation (Sancho et al., 1998).  
Evidence exists that ubiquitination is also important for the assembly and function of 
neuronal circuits and that it is indeed critical to the growth cone behaviour at the midline in 
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Drosophila (Murphey and Godenschwege, 2002). Comm, the Robo-adaptor protein 
commissureless, regulates Robo removal from the growth cone surface as the growth cone 
approaches the midline. Recent studies suggest that ubiquitination of Comm and/or Robo 
plays a role in regulating Robo removal by affecting protein trafficking (Georgiou and 
Tear, 2002; Keleman et al., 2002; Myat et al., 2002). The first evidence that the ubiquitin 
pathway is involved in axon growth and guidance came by identification of an ubiquitin-
conjugating enzyme in Drosophila, which, when mutated in the catalytic domain, leads to 
pathfinding errors near the target cells in several neuronal projections (Muralidhar and 
Thomas, 1993; Oh et al., 1994). Moreover, in vitro experiments from Campbell et al. point 
to an important function for the ubiquitin system in growth cone attraction by Netrin/DCC 
signalling (Campbell and Holt, 2001). In addition to these functions in axon pathfinding 
and growth cone decisions at choice points, ubiquitin seems also to be involved in the 
establishment of neuromuscular synapses by removal of Comm from the muscle surface 
(Wolf et al., 1998). Synaptic stabilization during development and synaptic plasticity are 
regulated by ubiquitin as well (Burbea et al., 2002; DiAntonio et al., 2001; Fischer and 
Overstreet, 2002; reviewed by Hegde and DiAntonio, 2002; Hicke, 1999). Altogether, 
ubiquitination seems to be well implicated in the molecular remodelling and dynamic 
regulation of protein trafficking that occurs in growth cones and synapses.  
Furthermore, new findings suggest, that ubiquitination also plays a direct role in activation 
or suppression of gene expression (Conaway et al., 2002; reviewed by Hegde and 
DiAntonio, 2002; Ostendorff et al., 2002; Salghetti et al., 2001). Whether UEVs like 
MMS2 are part of such signalling pathways (possibly as regulators of E2 and E3 enzymes) 
is unknown and their functional role remains to be investigated. Interestingly, the highest 
expression of rMMS2 in rat brain is around birth in postmitotic neurons during the period 
of fiber outgrowth. This temporal regulation of expression suggests a distinct or additional 
role to DNA repair for rMMS2 in rat brain during neuronal differentiation. 
4.6 Conclusions and summary of the suppression subtractive 
 hybridisation 
In order to identify molecules that might positively influence axon growth, the subtraction 
approaches with cerebellum and entorhinal cortex at two developmental stages were 
performed in such a way that it was searched for positively acting, growth-promoting 
molecules, which are more abundant at the younger stage than in the more mature 
population. Yet, it is clear that with a subtraction approach, in which transcripts from 
mature, growth-incapable neurons become subtracted from young, growth-capable 
neurons, only genes can be identified that exhibit a pronounced downregulation during 
neuronal maturation. Of course, growth-associated genes might also be expressed 
continuously throughout postnatal neuronal development, in which case their growth-
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promoting function might be masked or inhibited by negatively acting molecules with 
progression of development. Myelin-associated growth inhibitors, whose expression arises 
during maturation of CNS neurons at the period when the growth-potential sharply 
declines (reviewed by Kapfhammer, 1997), might function as such negative regulators. 
They might influence the expression or signal transduction of growth-promoting molecules 
by retrograde regulation. It was shown, for example, that the lesion-induced cell body 
response is enhanced in Purkinje neurons after neutralization of myelin-associated growth 
inhibitors (Zagrebelsky et al., 1998). Moreover, target-derived retrogradely transported 
repressive factors might account for the decline of growth-associated proteins such as 
GAP-43 during neuronal maturation (Karimi-Abdolrezaee and Schreyer, 2002). A 
subtraction approach performed vice versa (subtract young from old), thus identifying 
sequences that are exclusively expressed in the mature neuronal population, would 
consider such inhibitory genes, which might become upregulated in the course of neuronal 
differentiation and which might negatively regulate growth-promoting genes as neuronal 
maturation proceeds. 
To summarize, the gradual decline in the axon growth capability of maturing CNS neurons 
may be attributable to either intrinsic modifications associated with the acquisition of the 
adult neuronal phenotype (Bates and Meyer, 1997), the progressive appearance of growth 
inhibitory signals (reviewed by Kapfhammer, 1997) or disappearance of growth-promoting 
factors (Kalil and Skene, 1986; reviewed by Skene, 1989). Concerning the first issue, an 
intrinsic change of gene expression patterns of CNS neurons during postnatal development 
and differentiation, the results presented here are a fist step towards identifying molecules 
that might be associated with axon growth. By the method of suppressive subtractive 
hybridisation, two subtractive libraries from E18-cerebellum and P0-entorhinal cortex, 
respectively, were generated, which allowed the enrichment of genes that are actively 
transcribed in rat brain around birth but which are silent or much less transcribed after 
establishment of neuronal circuits. Several genes were identified that exhibited a distinct 
temporal regulation during postnatal brain development with higher expression levels 
during the young, immature developmental stage. The efficiency of this approach was 
proven by the enrichment of numerous genes whose developmental expression or 
association with axon growth had previously been described. Two molecules, rCRHSP-24 
and the novel rat gene rMMS2, were demonstrated for the first time to be highly expressed 
in neurons of various brain regions at the neonatal stage and to be extensively 
downregulated after the critical period of axon elongation. Although the precise role of 
both proteins during neuronal development is not yet clear, rMMS2, as possible player in 
ubiquitin-mediated modification of target proteins, and rCRHSP-24, which probably is 
implicated in Ca2+/calmodulin-mediated signalling pathways, might function as indirect 
modulators of axon growth. At least, their high expression during axonal outgrowth in 
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CNS neurons in many brain regions and their strong downregulation during postnatal 
development point to a role of these proteins in neuronal differentiation of CNS neurons. 
4.7 Outlook 
As two molecules, rMMS2 and CRHSP-24, whose expression or function in nervous 
system development had not been examined before, exhibited a strong downregulation in 
CNS neurons during postnatal maturation, it would be of great interest to follow up these 
subtracted candidates. As a first step, the expression of MMS2 and CRHSP-24 proteins 
should be analysed in order to find out whether the regulation of these two molecules 
occurs similarly on the transcript and protein level. If so, it is obvious that future 
experiments would concentrate on the function that both proteins occupy during 
differentiation of CNS neurons. One way to study this could be in slice cultures as 
organotypic cultures with cerebellum and entorhinal cortex, respectively, are well 
established (Dusart et al., 1997; Li et al., 1995; Prang et al., 2001; Woodhams et al., 1993). 
Applying the method of antisense-oligonucleotides on cerebellar slices or entorhino-
hippocampal co-cultures at the time when both genes normally are highly expressed, one 
could investigate the effects of blocking the transcription of rMMS2 and CRHSP-24, 
respectively. Since transcripts of rMMS2 and CRHSP-24 are very abundant in CNS 
neurons during the period of axonal outgrowth and axonal projections develop well in the 
two slice culture models, it could be nicely studied whether blocking the subtracted 
candidate molecules would have any effect on axon growth of Purkinje neurons and 
entorhinal pyramidal cells, respectively. Conversely, one could try to force the expression 
of rMMS2 and CRHSP-24 in these neurons, e.g. by transfection with a gene gun or viral 
infection, at a time point when expression of both molecules is already downregulated. As 
this later developmental stage correlates with the strong decline in axon growth-potential 
of CNS neurons, it would be attractive to investigate whether ectopic expression of both 
proteins could ameliorate the growth behaviour of mature Purkinje cells and entorhinal 
pyramidal neurons. Moreover, co-immunprecipitation experiments or the yeast two-hybrid 
system could be applied in order to identify possible interaction partners of rMMS2 and 
CRHSP-24. This would be a first step towards elucidating the signal cascades involved in 
mediating rMMS2 and CRHSP-24 actions. Immunfluorescence analysis could provide 
information about the intracellular localisation of the proteins, which would be of interest 
in regard to the possible functions of both proteins in DNA-binding that occurs in the 
nucleus. 
Furthermore, many other subtracted clones are still awaiting their further analysis. 
Expression studies of yet uncharacterised subtracted cDNAs could yield additional 
interesting candidate molecules that are downregulated during postnatal development. 
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5 Summary 
During neuronal development CNS neurons extend axons over long distances. This high 
growth potential is lost during postnatal development resulting in very poor axonal 
outgrowth and regeneration in the adult CNS. This pronounced decline of axon growth 
potential and regenerative capability might be related to alterations in the expression level 
of growth-associated genes during postnatal development. The aim of the present study 
was the identification of candidate molecules that might be associated with axon growth, 
i.e. which are strongly expressed during axonal outgrowth and are downregulated as 
neuronal maturation proceeds. As the time periods of developmental axonal outgrowth and 
decrease in growth potential are well studied in rat cerebellum and entorhinal cortex, these 
two brain regions were chosen as model systems for analysis of gene expression patterns 
during axonal extension and after completion of pathway formation. In a first approach the 
study focused on the identification of transcription factors, because they are known to be 
involved in the regulation of cellular identity and differentiation and hence might also 
determine the intrinsic growth state of a neuron. In order to identify transcription factors 
from rat cerebellum and entorhinal cortex at the time of maximal axonal outgrowth, PCR 
with degenerate oligonucleotides, specific for the conserved DNA-binding domains of 
distinct transcription factor classes, was performed with cDNA from cerebellum at E18 
and entorhinal cortex at P0, respectively. A limited number of PCR products could be 
isolated from the above brain regions by the use of primers for the POU and zinc finger 
family of transcription factors. Because of the small number of candidate molecules and 
considerable difficulties in constructing cDNA probes for further analysis this approach 
was not further pursued. A second approach aimed at the comparison of the transcriptional 
activity of young differentiating CNS neurons, which extend axons, with that of more 
mature neurons, which have lost growth competence. The method of suppression 
subtractive hybridisation (SSH) was performed in two distinct CNS tissues, rat cerebellum 
and entorhinal cortex, at two developmental stages (E18 and P35 for cerebellum and P0 an 
P10 for entorhinal cortex, respectively) in order to enrich for genes, which are 
downregulated during postnatal development. Several differentially expressed genes were 
identified, and the temporal and spatial expression pattern of some of these genes was 
further examined in rat brain by Northern- and in situ-hybridisation analysis at different 
developmental stages. One of the identified genes, rMMS2, was not known in the rat 
before and was characterised in this study for the first time. In addition, CRHSP-24, whose 
expression pattern had not previously been examined in the developing brain, was 
identified as a differentially expressed gene. Further analysis showed that rMMS2 and 
CRHSP-24 were strongly expressed in many brain regions during late embryonic and early 
postnatal development. Expression of both genes was significantly downregulated during 
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the first postnatal weeks and was only weak or absent in the adult brain. As this regulated 
distribution correlates well with the time period of establishment of axonal connections in 
the developing brain, these molecules might play a role in neuronal differentiation 
processes. However, their function in neuronal development is not yet clear and remains to 
be elucidated. Because only a fraction of the enriched genes has been analysed by now the 
pool of subtracted genes might serve as a valuable source for the identification of further 
candidate genes, which might be associated with neuronal differentiation and axonal 
outgrowth. 
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6 Zusammenfassung 
Nervenzellen (Neurone) des Zentralen Nervensystems (ZNS) bilden während der 
Entwicklung des Nervensystems lange Fortsätze aus, die Axone, die in das zukünftige 
Innervationsgebiet wachsen, um dort synaptische Kontakte mit den Zielneuronen zu 
formen. Dieses Auswachsen der Axone ist auf eine relativ kurze Zeitspanne während der 
Entwicklung des Gehirns begrenzt. Ist diese Periode verstrichen, geht die Fähigkeit der 
Neurone zum Axonwachstum stark zurück. Dies führt unter anderem dazu, dass im adulten 
Gehirn nach Durchtrennung bestehender Axone kaum axonale Regeneration möglich ist. 
Ein wichtiger Grund für das mangelhafte Faserwachstum in adulten, ausdifferenzierten 
Neuronen könnte das Fehlen von Molekülen sein, die das Axonwachstum anregen oder 
positiv beeinflussen, und die in Neuronen des ZNS nur während der Periode des massiven 
Axonwachstums in der Entwicklung, aber nicht mehr zu einem späteren Zeitpunkt gebildet 
werden. Das Ziel der vorliegenden Studien war deshalb, solche Moleküle zu identifizieren, 
die während der Periode des Axonwachstums in Neuronen des ZNS stark exprimiert 
werden, deren Expression aber zu einem späteren Zeitpunkt, wenn die axonalen 
Verbindungen fertig ausgebildet sind, erheblich zurückgeht. Da das kritische Zeitfenster, in 
dem Faserwachstum möglich ist, im Cerebellum und Entorhinalen Cortex der Ratte zuvor 
genau untersucht und beschrieben worden war, eigneten sich diese beiden Gehirnregionen 
besonders gut, um Axonwachstums-assoziierte Kandidatenmoleküle zu suchen. Zwei 
Methoden wurden hierfür angewandt. Die erste, die Methode der „degenerierten PCR“, 
fokussierte auf eine bestimmte Molekülklasse, die Transkriptionsfaktoren, da diese 
regulatorisch wirksame Proteine sind, welche die Expression vieler Zielgene beeinflussen 
und eine wichtige Rolle bei der Entwicklung des Nervensystems spielen. Mittels PCR mit 
degenerierten Primern wurden die konservierten DNA-Bindungsdomänen verschiedener 
Klassen von Transkriptionsfaktoren, zum Beispiel der POU- oder Zinkfinger- Familie, 
amplifiziert. Wegen der geringen Zahl an isolierten Molekülen und Schwierigkeiten bei der 
Herstellung von spezifischen RNA-Sonden für eine anschließende Hybridisierung wurde 
dieser Ansatz nicht weitergeführt. Deshalb wurde eine zweite Methode, die „Subtraktive 
Hybridisierung“, angewandt. Diese Methode erlaubt es, zwei verschiedene mRNA-
Populationen miteinander zu vergleichen und solche Transkripte zu finden, die 
ausschließlich oder verstärkt in einer der beiden Gruppen vorhanden sind. Hier wurden die 
mRNA-Populationen aus zwei verschiedenen Entwicklungsstadien miteinander verglichen, 
einem frühen Stadium, wenn Axone auswachsen, und einem späteren, wenn kein 
Axonwachstum mehr möglich ist. Diese vergleichenden Studien wurden in zwei 
unterschiedlichen Ansätzen einmal im Cerebellum der Ratte und zum anderen im 
Entorhinalen Cortex der Ratte durchgeführt. Damit konnten mehrere Gene identifiziert 
werden, die differenziell reguliert werden, das heißt, die in jungen, auswachsenden 
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Neuronen stark exprimiert werden, die jedoch nach der kritischen Periode herunterreguliert 
werden und in adulten Neuronen kaum mehr vorhanden sind. Eines der subtrahierten 
Kandidatengene, rMMS2, war in der Ratte noch unbekannt und wurde hier zum ersten Mal 
beschrieben. Dieses und ein weiteres Gen, CRHSP-24, dessen Aktivität im sich 
entwickelnden Gehirn der Ratte noch nicht beschrieben war, wurden mittels Northern- und 
in situ-Hybridisierungen auf ihre Expression hin untersucht. Es konnte gezeigt werden, 
dass beide Gene zum Zeitpunkt der Geburt in vielen Gebieten des Gehirns stark exprimiert 
werden, ihre Expression aber während der postnatalen Entwicklung erheblich zurückgeht 
und im adulten Gehirn nur noch schwach nachgewiesen werden kann. Dieser Zeitverlauf 
entspricht der Entwicklungsperiode, in der viele axonale Verbindungen gebildet werden 
und lässt darauf schließen, dass diese Proteine bei neuronalen Differenzierungsprozessen 
eine wichtige Rolle spielen könnten. Ihre genauere Funktion ist allerdings noch ungeklärt 
und bedarf weiterer Untersuchungen. Bisher konnte nur ein kleiner Teil der durch die 
subtraktive Hybridisierung identifizierten Gene genauer untersucht werden. Alle übrigen 
Gene, die durch diese Methode angereichert und bislang noch nicht charakterisiert wurden, 
bilden einen interessanten Ausgangspunkt für die Identifizierung weiterer Kandidatengene, 
die an der Regulation von neuronaler Differenzierung und axonalem Wachstums beteiligt 
sein könnten.  
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8 Appendix 
8.1 Supplier list 
Apelex Z.I. de la Bonde, 6, rue Marcel Paul, 91742 Massy Cedex, F 
AppliChem GmbH Ottoweg 10b, 64291 Darmstadt, D 
Applied Biosystems Rotkreuz Branch, Grundstrasse 10, 6343 Rotkreuz, CH 
Axon Lab AG Täfernstrasse 15, 5405 Baden-Dättwil, CH 
BD Biosciences AG Binningerstrasse 94, 4123 Allschwil, CH 
Bio-Rad Laboratories AG Nenzlingerweg 2, 4153 Reinach BL, CH 
Catalys AG (Promega) Industriestrasse 28, 8304 Wallisellen, CH 
Charles River Lab., Inc. 251 Ballardvale Street, Willmington, MA 01887-1000, USA 
Clontech Laboratories AG Matthäusstrasse 18, 4057 Basel, CH 
Diagnostic Instr. Inc. 6540 Burroughs St. Sterling Heights, Michigan 48314-2133, USA 
Fluka Chemie GmbH Industriestrasse 25, 9471 Buchs, CH 
Gibco BRL see: Invitrogen AG 
Heidolph Instruments Walpersdorfer Strasse 12, 91126 Schwabach, D 
Heraeus see: Kendro 
IKA-Werke GmbH & Co. KG Jahnke & Kunkel-Strasse 10, 79219 Staufen, D 
Intas GmbH Florenz-Sartorius-Strasse 14, 37079 Göttingen, D 
Invitrogen AG Uferstrasse 90, 40190 Basel, CH 
R. Jung GmbH Heidelberger Strasse 17-19, 69226 Nussloch, D 
Kendro Laboratory Products AG Räffelstrasse 32, Postfach, 8045 Zürich, CH 
Leica Microsystems AG Kanalstrasse 21, 8152 Glattbrugg, CH 
Life Technologies see: Invitrogen AG 
Macherey-Nagel AG Hirsackerstrasse 7, 4702 Oensingen, CH 
Menzel-Gläser Postfach 3157, 38021 Braunschweig, D 
Merck Sharp & Dohme-Chibret AG Schaffhauserstrasse 136, 8152 Glattbrugg, CH 
Mettler-Toledo AG Im Langacher, P.O. BOX, 8606 Greifensee, CH 
Milian AG Claragraben 132a, 4057 Basel, CH 
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MWG-Biotech AG Grabenackerstrasse 11, 4142 Münchenstein, CH 
Ohaus Germany Ockerweg 3a, 35396 Giessen, D 
Olympus Optical AG Chriesbaumstrasse 6, 8604 Volketswil, CH 
OWL Separation Systems 55 Heritage Avenue, Portsmouth, NH 03801, USA 
Peqlab Biotechnologie GmbH Am Weichselgarten 7, 91058 Erlangen, D 
Pharmacia AG (Amersham Biosciences Europe) Lagerstrasse 14, 8600 Dübendorf, CH 
Polylabo SA 35, route du Vélodrome, 1228 Plan-les-Ouates / Genève CH 
Qiagen AG Auf dem Wolf 39, 4052 Basel, CH 
Roche Diagnostics AG Industriestrasse 7, 6343 Rotkreuz, CH 
Roth AG Christoph Merian-Ring 7, 4153 Reinach BL1, CH 
Schleicher & Schuell GmbH Grimsehlstrasse 23, 37574 Einbeck, D 
Sigma-Aldrich Chemie GmbH Eschenstrasse 5, 82024 Taufkirchen, D 
Stratagene Europe P.O. Box 12085, 1100 AB Amsterdam, NL 
Vaudaux-Eppendorf AG Im Kirschgarten 30, 4124 Schönenbuch / Basel, CH 
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8.2 Abbreviation index 
approx. approximately 
BCIP 5-bromo-4-chloro-3-indolyl phosphate p-toluidine salt 
BDNF brain derived neurotrophic growth factor 
bHLH basic helix-loop-helix 
bp base pairs 
CA1-CA3 cornu ammonis regions of the hippocampal formation 
CAM cell adhesion molecule 
cAMP cyclic adenosine monophosphate 
cDNA complementary DNA 
CDR coding region 
CDS coding sequence 
CE cerebellum 
C.elegans Caenorhabditis elegans 
CNS central nervous system 
ddH2O distilled deionised water 
DIG digoxigenin 
DMF dimethylformamide 
DNA deoxyribonucleic acid 
DNase deoxyribonuclease 
DRG dorsal root ganglion 
EC entorhinal cortex 
EDTA ethylenediaminetetraacetate 
E embryonic day 
E. coli Escherichia coli 
EST expressed sequence tag 
GDNF glial derived neurotrophic growth factor 
GFP green fluorescent protein 
HOX homeobox 
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IEG immediate early gene 
Ig immunglobulin 
kb kilo bases 
kDa kilo Dalton 
LTD long term depression 
LTP long term potentiation 
M molar 
mM milli molar 
µg microgram 
MOPS 3-morpholinopropanesulfonic acid 
mRNA messenger ribonucleic acid 
NBT nitroblue tetrazolium chloride 
NGF nerve growth factor 
NT neurotrophin 
ORF open reading frame 
P postnatal day 
PBS phosphate buffered saline 
PC12 phaeochromocytoma cells (a neuroendocrine cell line) 
PCR polymerase chain reaction 
PNS peripheral nervous system 
RGC retinal ganglion cell 
RNA ribonucleic acid 
RNase ribonuclease 
SDS sodium dodecyl sulfate 
SSC sodium citrate buffer 
SSH suppression subtractive hybridisation 
UTR untranslated region 
UV ultraviolet 
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8.3 Publications 
Parts of this work were published as poster presentations or in scientific journals: 
Hofsaess, U. and Kapfhammer J.P. (2003) Identification of numerous genes differentially 
expressed in rat brain during postnatal development and expression analysis of the novel 
rat gene rMMS2. Brain Res Mol Brain Res, in press 
Hofsäss,U. and Kapfhammer J.P. Identification of genes differentially expressed in rat 
cerebellum and entorhinal cortex during development. FENS Abstr. vol 1, A138.10, 2002 
Hofsaess, U. and Kapfhammer J.P., Identification of genes differentially expressed in rat 
cerebellum and entorhinal cortex during development. Soc. Neurosci. Abstr., Vol. 27, 
795.8, 2001 
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